Provide professional ppt using above content

I'll read the PPTX skill first, then extract the content from the uploaded file to create a professional presentation.

Reading File

Now let me extract the content from the uploaded PPTX file:

Running Command

python -m markitdown "/home/daytona/workspace/attachments/d5c14b05-c595-4513-9bc8-0a6ea537f76f/Plaque Psoriasis Case.pptx"

Running Command

cd /home/daytona/workspace && python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/workspace/attachments/d5c14b05-c595-4513-9bc8-0a6ea537f76f/Plaque Psoriasis Case.pptx') for i, slide in enumerate(prs.slides): print(f'=== SLIDE {i+1} ===') for shape in slide.shapes: if hasattr(shape, 'text') and shape.text.strip(): print(f' [{shape.shape_type}] {repr(shape.text[:500])}') print() "

Running Command

cd /home/daytona/workspace && pip install python-pptx --quiet && python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/workspace/attachments/d5c14b05-c595-4513-9bc8-0a6ea537f76f/Plaque Psoriasis Case.pptx') for i, slide in enumerate(prs.slides): print(f'=== SLIDE {i+1} ===') for shape in slide.shapes: if hasattr(shape, 'text') and shape.text.strip(): print(f' [{shape.shape_type}] {repr(shape.text[:800])}') print() " 2>&1 | tail -60

I have all the content. Now let me also check if there's a lab data table or image on slide 7-8:

Running Command

python3 -c " from pptx import Presentation from pptx.util import Inches prs = Presentation('/home/daytona/workspace/attachments/d5c14b05-c595-4513-9bc8-0a6ea537f76f/Plaque Psoriasis Case.pptx') for i in [6,7,12]: # slides 7,8,13 (0-indexed) slide = prs.slides[i] print(f'=== SLIDE {i+1} ===') for shape in slide.shapes: print(f' shape_type={shape.shape_type}, name={shape.name}') if shape.has_table: tbl = shape.table print(f' TABLE: {tbl.rows.__len__()} rows x {tbl.columns.__len__()} cols') for row in tbl.rows: row_data = [cell.text.strip() for cell in row.cells] print(' ', row_data) if hasattr(shape, 'text') and shape.text.strip(): print(f' TEXT: {repr(shape.text[:600])}') print() "

I have all the content. Now I'll build a professional, visually polished presentation:

Running Command

mkdir -p /home/daytona/workspace/plaque-psoriasis-ppt && ls /home/daytona/workspace/plaque-psoriasis-ppt/

Writing File

~/plaque-psoriasis-ppt/build.js

const pptxgen = require("pptxgenjs");

const prs = new pptxgen();
prs.layout = "LAYOUT_16x9";
prs.title = "Plaque Psoriasis Case";
prs.author = "Ganavi C";

// ─── COLOUR PALETTE ───────────────────────────────────────────────
const DARK_BG    = "0D1B2A";   // deep navy
const MID_BG     = "1B3A5C";   // rich blue
const ACCENT     = "3AB4F2";   // sky-blue accent
const ACCENT2    = "F26B3A";   // warm coral for highlights
const WHITE      = "FFFFFF";
const LIGHT_TEXT = "D0E8F5";
const CARD_BG    = "132840";   // card background
const TABLE_HDR  = "1E4D78";
const TABLE_ROW1 = "0F2236";
const TABLE_ROW2 = "132840";
const GREEN_OK   = "4CAF50";
const RED_FLAG   = "EF5350";

// Helper – add a dark slide background with optional top accent bar
function addBg(slide, barColor) {
  slide.addShape(prs.ShapeType.rect, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: DARK_BG } });
  if (barColor) {
    slide.addShape(prs.ShapeType.rect, { x: 0, y: 0, w: 10, h: 0.07, fill: { color: barColor } });
    slide.addShape(prs.ShapeType.rect, { x: 0, y: 5.555, w: 10, h: 0.07, fill: { color: barColor } });
  }
}

// Helper – section header band
function sectionBand(slide, label, y) {
  slide.addShape(prs.ShapeType.rect, { x: 0, y: y, w: 10, h: 0.44, fill: { color: MID_BG } });
  slide.addShape(prs.ShapeType.rect, { x: 0, y: y, w: 0.06, h: 0.44, fill: { color: ACCENT } });
  slide.addText(label, { x: 0.15, y: y, w: 9.6, h: 0.44, fontSize: 11, bold: true, color: ACCENT, valign: "middle", margin: 0 });
}

// Helper – info card
function card(slide, x, y, w, h, title, lines) {
  slide.addShape(prs.ShapeType.rect, { x, y, w, h, fill: { color: CARD_BG }, line: { color: ACCENT, width: 1 } });
  slide.addText(title, { x: x + 0.12, y: y + 0.08, w: w - 0.24, h: 0.3, fontSize: 9, bold: true, color: ACCENT, margin: 0 });
  const items = lines.map((l, i) => ({ text: l, options: { breakLine: i < lines.length - 1, bullet: false } }));
  slide.addText(items, { x: x + 0.12, y: y + 0.38, w: w - 0.24, h: h - 0.5, fontSize: 8, color: LIGHT_TEXT, valign: "top", margin: 0 });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 1 – TITLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  // background
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: DARK_BG } });
  // dramatic left panel
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0, w: 3.6, h: 5.625, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 3.6, y: 0, w: 0.06, h: 5.625, fill: { color: ACCENT } });
  // decorative circles
  s.addShape(prs.ShapeType.ellipse, { x: 0.4, y: 0.3, w: 1.4, h: 1.4, fill: { color: ACCENT, transparency: 80 } });
  s.addShape(prs.ShapeType.ellipse, { x: 1.8, y: 3.9, w: 1.8, h: 1.8, fill: { color: ACCENT2, transparency: 85 } });
  // Left panel text
  s.addText("CASE\nREPORT", { x: 0.15, y: 1.0, w: 3.2, h: 1.2, fontSize: 28, bold: true, color: ACCENT, align: "center", charSpacing: 8 });
  s.addShape(prs.ShapeType.line, { x: 0.5, y: 2.25, w: 2.6, h: 0, line: { color: ACCENT2, width: 2 } });
  s.addText("Dermatology &\nClinical Pharmacy", { x: 0.15, y: 2.4, w: 3.2, h: 0.8, fontSize: 11, color: LIGHT_TEXT, align: "center", italic: true });
  // Presenter box
  s.addShape(prs.ShapeType.rect, { x: 0.25, y: 3.5, w: 3.1, h: 1.6, fill: { color: DARK_BG }, line: { color: ACCENT, width: 1 } });
  s.addText("PRESENTED BY", { x: 0.35, y: 3.6, w: 2.9, h: 0.3, fontSize: 8, bold: true, color: ACCENT2, align: "center", charSpacing: 3 });
  s.addText([
    { text: "Ganavi C", options: { breakLine: true, bold: true } },
    { text: "V Pharm D", options: { breakLine: true } },
    { text: "21Q0275", options: {} }
  ], { x: 0.35, y: 3.95, w: 2.9, h: 0.9, fontSize: 11, color: WHITE, align: "center" });

  // Main title area
  s.addText("Plaque Psoriasis", { x: 3.9, y: 0.7, w: 5.8, h: 1.1, fontSize: 36, bold: true, color: WHITE });
  s.addText("Clinical Case Study", { x: 3.9, y: 1.8, w: 5.8, h: 0.6, fontSize: 20, color: ACCENT, italic: true });
  s.addShape(prs.ShapeType.line, { x: 3.9, y: 2.5, w: 5.5, h: 0, line: { color: ACCENT2, width: 1.5 } });
  // Key disease tags
  const tags = ["Severe", "Chronic", "Uncontrolled", "Biologic Candidate"];
  tags.forEach((t, i) => {
    const tx = 3.9 + i * 1.5;
    s.addShape(prs.ShapeType.roundRect, { x: tx, y: 2.7, w: 1.38, h: 0.34, fill: { color: ACCENT2, transparency: 20 }, rectRadius: 0.05 });
    s.addText(t, { x: tx, y: 2.7, w: 1.38, h: 0.34, fontSize: 8, bold: true, color: WHITE, align: "center", valign: "middle", margin: 0 });
  });
  s.addText("A 50-year-old male with a 27-year history of plaque psoriasis presenting\nwith severe, uncontrolled disease despite multiple lines of therapy.", {
    x: 3.9, y: 3.2, w: 5.8, h: 0.9, fontSize: 10, color: LIGHT_TEXT, italic: true
  });
  // Bottom bar
  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("V Pharm D  |  Clinical Pharmacy Case Presentation  |  2024", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 2 – SUBJECTIVE: PATIENT PROFILE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  // Title bar
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("SUBJECTIVE DATA", { x: 0.18, y: 0.07, w: 5, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });
  s.addText("Patient Profile", { x: 5.2, y: 0.07, w: 4.6, h: 0.65, fontSize: 11, color: LIGHT_TEXT, valign: "middle", italic: true, align: "right", margin: 0 });

  // Patient info card (left)
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.87, w: 4.5, h: 3.0, fill: { color: CARD_BG }, line: { color: ACCENT, width: 0.75 } });
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.87, w: 4.5, h: 0.38, fill: { color: MID_BG } });
  s.addText("PATIENT INFORMATION", { x: 0.3, y: 0.87, w: 4.3, h: 0.38, fontSize: 9, bold: true, color: ACCENT, valign: "middle", charSpacing: 2, margin: 0 });

  const patRows = [
    ["Age", "50 years"], ["Gender", "Male"], ["Occupation", "Elementary School Teacher"],
    ["Weight", "75 kg"], ["Height", "5'9\""], ["Allergies", "NKA"]
  ];
  patRows.forEach(([k, v], i) => {
    const ry = 1.32 + i * 0.4;
    const fill = i % 2 === 0 ? TABLE_ROW1 : TABLE_ROW2;
    s.addShape(prs.ShapeType.rect, { x: 0.2, y: ry, w: 4.5, h: 0.38, fill: { color: fill } });
    s.addText(k, { x: 0.32, y: ry, w: 1.8, h: 0.38, fontSize: 9, bold: true, color: ACCENT, valign: "middle", margin: 0 });
    s.addText(v, { x: 2.15, y: ry, w: 2.4, h: 0.38, fontSize: 9, color: WHITE, valign: "middle", margin: 0 });
  });

  // Chief complaint
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 0.87, w: 4.75, h: 1.1, fill: { color: CARD_BG }, line: { color: ACCENT2, width: 1 } });
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 0.87, w: 4.75, h: 0.35, fill: { color: ACCENT2, transparency: 30 } });
  s.addText("CHIEF COMPLAINT", { x: 5.1, y: 0.87, w: 4.5, h: 0.35, fontSize: 9, bold: true, color: WHITE, valign: "middle", charSpacing: 2, margin: 0 });
  s.addText('"Nothing is helping my psoriasis."', { x: 5.1, y: 1.25, w: 4.5, h: 0.65, fontSize: 12, color: LIGHT_TEXT, italic: true, valign: "middle" });

  // Social & Family History
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 2.1, w: 4.75, h: 1.77, fill: { color: CARD_BG }, line: { color: ACCENT, width: 0.75 } });
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 2.1, w: 4.75, h: 0.35, fill: { color: MID_BG } });
  s.addText("SOCIAL & FAMILY HISTORY", { x: 5.1, y: 2.1, w: 4.5, h: 0.35, fontSize: 9, bold: true, color: ACCENT, valign: "middle", charSpacing: 2, margin: 0 });
  const socLines = [
    "• Former heavy smoker",
    "• Drinks one glass of wine daily",
    "• Increased occupational stress",
    "• Married with children",
    "• Brother: Psoriasis | Father: HTN, T2DM"
  ];
  s.addText(socLines.map((l, i) => ({ text: l, options: { breakLine: i < socLines.length - 1 } })), {
    x: 5.1, y: 2.5, w: 4.5, h: 1.3, fontSize: 9, color: LIGHT_TEXT, valign: "top"
  });

  // PMH
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 3.98, w: 4.5, h: 0.58, fill: { color: CARD_BG }, line: { color: ACCENT2, width: 0.75 } });
  s.addText("PAST MEDICAL HISTORY", { x: 0.32, y: 3.98, w: 2.5, h: 0.3, fontSize: 8, bold: true, color: ACCENT2, margin: 0 });
  s.addText("Major depressive episode — 16 years ago", { x: 0.32, y: 4.3, w: 4.2, h: 0.22, fontSize: 8.5, color: LIGHT_TEXT, margin: 0 });

  // Footer
  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 2  |  Subjective Data – Patient Profile", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 3 – HISTORY OF PRESENT ILLNESS (split across 2 slides condensed)
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("HISTORY OF PRESENT ILLNESS", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  // Timeline
  const events = [
    { age: "23 yrs", label: "Diagnosis", detail: "Plaque Psoriasis diagnosed\nInitial control: medium-potency topical corticosteroids" },
    { age: "Mid-30s", label: "Calcipotriol Added", detail: "Topical corticosteroids alone insufficient\nCalcipotriol therapy added" },
    { age: "Later", label: "PUVA Phototherapy", detail: "Psoralen + UVA initiated\nTemporary improvement, gradually lost effectiveness" },
    { age: "Ongoing", label: "Methotrexate", detail: "Escalated to 25 mg/week\nCumulative dose: 2.2 g\nShort-contact anthralin (SCAT) for acute flares" },
    { age: "1 yr ago", label: "Cyclosporine + Acitretin", detail: "Acitretin DC'd: severe xerosis\nCyclosporine 75 mg BD alone — 1 yr good control" },
    { age: "Now", label: "3rd Severe Flare", detail: "2 severe flares in past 6 months\nCurrent: most severe presentation yet" }
  ];

  const colors = [ACCENT, "#3AB4F2", "#2E9BD4", "#F26B3A", "#E05520", RED_FLAG];
  events.forEach((e, i) => {
    const x = 0.2 + (i % 3) * 3.27;
    const y = i < 3 ? 0.9 : 3.05;
    const col = colors[i];

    s.addShape(prs.ShapeType.rect, { x, y, w: 3.1, h: 1.9, fill: { color: CARD_BG }, line: { color: col, width: 1 } });
    // top bar with age
    s.addShape(prs.ShapeType.rect, { x, y, w: 3.1, h: 0.38, fill: { color: col, transparency: 20 } });
    s.addText(e.age, { x: x + 0.1, y, w: 1.2, h: 0.38, fontSize: 8.5, bold: true, color: WHITE, valign: "middle", margin: 0 });
    s.addText(e.label, { x: x + 1.3, y, w: 1.7, h: 0.38, fontSize: 8, color: WHITE, valign: "middle", align: "right", margin: 0 });
    s.addText(e.detail, { x: x + 0.1, y: y + 0.44, w: 2.9, h: 1.35, fontSize: 8.5, color: LIGHT_TEXT, valign: "top" });
  });

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 3  |  Subjective – HPI Timeline", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 4 – OBJECTIVE: VITALS & PHYSICAL EXAM
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("OBJECTIVE DATA", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  // Vital signs – 4 cards
  const vitals = [
    { label: "Blood Pressure", val: "129/83", unit: "mmHg", flag: false },
    { label: "Pulse", val: "88", unit: "bpm", flag: false },
    { label: "Temperature", val: "37.0", unit: "°C", flag: false },
    { label: "Appearance", val: "Alert", unit: "Mild anxiety", flag: false }
  ];
  vitals.forEach((v, i) => {
    const x = 0.2 + i * 2.45;
    s.addShape(prs.ShapeType.rect, { x, y: 0.85, w: 2.3, h: 1.1, fill: { color: CARD_BG }, line: { color: ACCENT, width: 0.75 } });
    s.addShape(prs.ShapeType.rect, { x, y: 0.85, w: 2.3, h: 0.3, fill: { color: MID_BG } });
    s.addText(v.label, { x: x + 0.08, y: 0.85, w: 2.14, h: 0.3, fontSize: 8, bold: true, color: ACCENT, valign: "middle", margin: 0 });
    s.addText(v.val, { x: x + 0.08, y: 1.18, w: 2.14, h: 0.45, fontSize: 20, bold: true, color: WHITE, valign: "middle", align: "center" });
    s.addText(v.unit, { x: x + 0.08, y: 1.63, w: 2.14, h: 0.28, fontSize: 9, color: LIGHT_TEXT, align: "center" });
  });

  // Skin exam
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 2.1, w: 9.6, h: 2.85, fill: { color: CARD_BG }, line: { color: ACCENT2, width: 0.75 } });
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 2.1, w: 9.6, h: 0.38, fill: { color: ACCENT2, transparency: 30 } });
  s.addText("SKIN EXAMINATION – Severe Plaque Psoriasis", { x: 0.32, y: 2.1, w: 9.3, h: 0.38, fontSize: 10, bold: true, color: WHITE, valign: "middle", charSpacing: 1, margin: 0 });

  // Location grid
  const locs = ["Abdomen", "Arms", "Legs", "Back", "Scalp", "Palms", "Soles", "Elbows", "Knees"];
  locs.forEach((loc, i) => {
    const x = 0.35 + (i % 5) * 1.9;
    const y = 2.6 + Math.floor(i / 5) * 0.5;
    s.addShape(prs.ShapeType.roundRect, { x, y, w: 1.75, h: 0.38, fill: { color: RED_FLAG, transparency: 30 }, rectRadius: 0.04 });
    s.addText(loc, { x, y, w: 1.75, h: 0.38, fontSize: 9, bold: true, color: WHITE, align: "center", valign: "middle", margin: 0 });
  });

  // Characteristics
  const chars = ["Thick plaques", "Erythematous lesions", "Well-demarcated borders", "Confluent lesions", "Silvery-white scales", "Excoriations from scratching"];
  s.addText("Characteristics: ", { x: 0.35, y: 3.65, w: 1.6, h: 0.3, fontSize: 8.5, bold: true, color: ACCENT2, margin: 0 });
  s.addText(chars.join("   •   "), { x: 1.9, y: 3.65, w: 7.8, h: 0.3, fontSize: 8.5, color: LIGHT_TEXT, margin: 0 });

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 4  |  Objective Data – Vitals & Skin Exam", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 5 – LABORATORY DATA (Part 1: CBC + RFT + LFT)
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("LABORATORY DATA", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  // Left col – CBC
  const cbcData = [
    ["Hb", "13.5 g/dL", "13.5–17.5 g/dL", "N"],
    ["Hct", "35%", "40–52%", "L"],
    ["WBC", "6.0 ×10³/mm³", "4–11 × 10³/mm³", "N"],
    ["Platelets", "255 ×10³/mm³", "150–400 × 10³/mm³", "N"],
  ];
  const rftData = [
    ["BUN", "14 mg/dL", "7–20 mg/dL", "N"],
    ["Creatinine", "1.0 mg/dL", "0.6–1.3 mg/dL", "N"],
  ];
  const lftData = [
    ["AST (SGOT)", "22 IU/L", "10–40 IU/L", "N"],
    ["ALT (SGPT)", "38 IU/L", "7–56 IU/L", "N"],
    ["ALP", "98 IU/L", "44–147 IU/L", "N"],
    ["Total Bilirubin", "1.0 mg/dL", "0.1–1.2 mg/dL", "N"],
    ["Albumin", "3.7 g/dL", "3.5–5.0 g/dL", "N"],
  ];

  function labTable(slide, x, y, w, title, rows) {
    slide.addShape(prs.ShapeType.rect, { x, y, w, h: 0.35, fill: { color: TABLE_HDR } });
    slide.addText(title, { x: x + 0.08, y, w: w - 0.1, h: 0.35, fontSize: 9, bold: true, color: ACCENT, valign: "middle", margin: 0 });
    // header
    const hdrH = 0.32;
    const colW = [w * 0.38, w * 0.32, w * 0.22, w * 0.08];
    const hdrs = ["Parameter", "Result", "Normal", ""];
    slide.addShape(prs.ShapeType.rect, { x, y: y + 0.35, w, h: hdrH, fill: { color: MID_BG } });
    let cx = x;
    hdrs.forEach((h, ci) => {
      slide.addText(h, { x: cx + 0.04, y: y + 0.35, w: colW[ci] - 0.04, h: hdrH, fontSize: 7.5, bold: true, color: LIGHT_TEXT, valign: "middle", margin: 0 });
      cx += colW[ci];
    });
    rows.forEach((row, ri) => {
      const ry = y + 0.35 + hdrH + ri * 0.33;
      const fill = ri % 2 === 0 ? TABLE_ROW1 : TABLE_ROW2;
      slide.addShape(prs.ShapeType.rect, { x, y: ry, w, h: 0.33, fill: { color: fill } });
      let rcx = x;
      const vals = [row[0], row[1], row[2]];
      vals.forEach((v, ci) => {
        let col = LIGHT_TEXT;
        if (ci === 1 && row[3] === "L") col = ACCENT2;
        if (ci === 1 && row[3] === "H") col = RED_FLAG;
        slide.addText(v, { x: rcx + 0.04, y: ry, w: colW[ci] - 0.04, h: 0.33, fontSize: 8, color: col, valign: "middle", margin: 0 });
        rcx += colW[ci];
      });
      // flag badge
      if (row[3] === "L" || row[3] === "H") {
        const fc = row[3] === "L" ? ACCENT2 : RED_FLAG;
        slide.addShape(prs.ShapeType.roundRect, { x: x + w - colW[3] + 0.01, y: ry + 0.05, w: colW[3] - 0.02, h: 0.22, fill: { color: fc, transparency: 20 }, rectRadius: 0.04 });
        slide.addText(row[3], { x: x + w - colW[3] + 0.01, y: ry + 0.05, w: colW[3] - 0.02, h: 0.22, fontSize: 7, bold: true, color: WHITE, align: "center", valign: "middle", margin: 0 });
      }
    });
  }

  labTable(s, 0.2, 0.85, 4.55, "COMPLETE BLOOD COUNT", cbcData);
  labTable(s, 0.2, 3.05, 4.55, "RENAL FUNCTION TEST", rftData);
  labTable(s, 5.05, 0.85, 4.7, "LIVER FUNCTION TEST", lftData);

  // Electrolytes & others on right bottom
  const electData = [
    ["Sodium (Na⁺)", "139 mEq/L", "135–145 mEq/L", "N"],
    ["Potassium (K⁺)", "4.0 mEq/L", "3.5–5.0 mEq/L", "N"],
    ["Chloride (Cl⁻)", "102 mEq/L", "98–106 mEq/L", "N"],
    ["HCO₃⁻", "25 mEq/L", "22–28 mEq/L", "N"],
    ["Uric Acid", "4 mg/dL", "3.5–7.2 mg/dL", "N"],
    ["Total Cholesterol", "180 mg/dL", "<200 mg/dL", "N"],
    ["Blood Glucose", "98 mg/dL", "70–110 mg/dL", "N"],
  ];
  labTable(s, 5.05, 3.05, 4.7, "ELECTROLYTES & OTHERS", electData);

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 5  |  Laboratory Data", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 6 – ASSESSMENT
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("ASSESSMENT", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  // Diagnosis highlight
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 9.6, h: 0.7, fill: { color: RED_FLAG, transparency: 25 }, line: { color: RED_FLAG, width: 1 } });
  s.addText("PRIMARY DIAGNOSIS", { x: 0.4, y: 0.85, w: 3, h: 0.35, fontSize: 8, bold: true, color: WHITE, charSpacing: 2, margin: 0 });
  s.addText("Severe Chronic Plaque Psoriasis (Uncontrolled)", { x: 0.4, y: 1.2, w: 9.1, h: 0.32, fontSize: 13, bold: true, color: WHITE, margin: 0 });

  // Severity indicators – 3 metric boxes
  const metrics = [
    { label: "BSA Involvement", val: ">20%", sub: "Severe (>10% = Severe)" },
    { label: "Estimated PASI", val: ">20", sub: "Severe disease threshold" },
    { label: "Disease Duration", val: "27 yrs", sub: "Chronic, refractory" },
  ];
  metrics.forEach((m, i) => {
    const x = 0.2 + i * 3.27;
    s.addShape(prs.ShapeType.rect, { x, y: 1.7, w: 3.1, h: 1.05, fill: { color: CARD_BG }, line: { color: ACCENT2, width: 1 } });
    s.addText(m.label, { x: x + 0.1, y: 1.72, w: 2.9, h: 0.3, fontSize: 8, bold: true, color: ACCENT, margin: 0 });
    s.addText(m.val, { x: x + 0.1, y: 2.0, w: 2.9, h: 0.42, fontSize: 22, bold: true, color: WHITE, align: "center" });
    s.addText(m.sub, { x: x + 0.1, y: 2.42, w: 2.9, h: 0.28, fontSize: 7.5, color: LIGHT_TEXT, align: "center" });
  });

  // Areas affected
  const areas = ["Scalp", "Arms", "Legs", "Abdomen", "Back", "Palms", "Soles"];
  s.addText("Areas Affected:", { x: 0.25, y: 2.85, w: 2, h: 0.3, fontSize: 9, bold: true, color: ACCENT2, margin: 0 });
  areas.forEach((a, i) => {
    s.addShape(prs.ShapeType.roundRect, { x: 0.25 + i * 1.38, y: 3.18, w: 1.25, h: 0.3, fill: { color: MID_BG }, line: { color: ACCENT, width: 0.5 }, rectRadius: 0.04 });
    s.addText(a, { x: 0.25 + i * 1.38, y: 3.18, w: 1.25, h: 0.3, fontSize: 8.5, color: WHITE, align: "center", valign: "middle", margin: 0 });
  });

  // Drug Therapy Problems
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 3.6, w: 9.6, h: 1.55, fill: { color: CARD_BG }, line: { color: ACCENT, width: 0.75 } });
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 3.6, w: 9.6, h: 0.35, fill: { color: MID_BG } });
  s.addText("DRUG THERAPY PROBLEMS", { x: 0.32, y: 3.6, w: 9, h: 0.35, fontSize: 9, bold: true, color: ACCENT, valign: "middle", charSpacing: 2, margin: 0 });
  const dtps = [
    "1. Uncontrolled severe plaque psoriasis despite cyclosporine",
    "2. Inadequate response to current cyclosporine dose",
    "3. Previous failures: topicals, PUVA, methotrexate",
    "4. Acitretin intolerance (severe xerosis)",
    "5. Severe pruritus causing excoriations",
    "6. Stress-triggered disease flare-ups",
  ];
  const half = Math.ceil(dtps.length / 2);
  dtps.slice(0, half).forEach((d, i) => {
    s.addText(d, { x: 0.35, y: 4.0 + i * 0.36, w: 4.65, h: 0.32, fontSize: 8.5, color: LIGHT_TEXT, margin: 0 });
  });
  dtps.slice(half).forEach((d, i) => {
    s.addText(d, { x: 5.1, y: 4.0 + i * 0.36, w: 4.6, h: 0.32, fontSize: 8.5, color: LIGHT_TEXT, margin: 0 });
  });

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 6  |  Assessment & Drug Therapy Problems", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 7 – PLANNING: GOALS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("PLANNING", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  // Short-term goals
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 4.65, h: 3.35, fill: { color: CARD_BG }, line: { color: ACCENT, width: 1 } });
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 4.65, h: 0.4, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 0.07, h: 0.4, fill: { color: ACCENT } });
  s.addText("SHORT-TERM GOALS  (4–8 Weeks)", { x: 0.35, y: 0.85, w: 4.4, h: 0.4, fontSize: 10, bold: true, color: ACCENT, valign: "middle", charSpacing: 1, margin: 0 });
  const st = ["Reduce erythema (redness)", "Reduce scaling", "Relieve itching (pruritus)", "Stop disease progression", "Improve sleep and comfort"];
  st.forEach((g, i) => {
    const ry = 1.35 + i * 0.5;
    s.addShape(prs.ShapeType.ellipse, { x: 0.35, y: ry + 0.08, w: 0.22, h: 0.22, fill: { color: ACCENT } });
    s.addText(`${i + 1}`, { x: 0.35, y: ry + 0.08, w: 0.22, h: 0.22, fontSize: 8, bold: true, color: DARK_BG, align: "center", valign: "middle", margin: 0 });
    s.addText(g, { x: 0.65, y: ry, w: 4.1, h: 0.4, fontSize: 10, color: LIGHT_TEXT, valign: "middle" });
  });

  // Long-term goals
  s.addShape(prs.ShapeType.rect, { x: 5.15, y: 0.85, w: 4.65, h: 3.35, fill: { color: CARD_BG }, line: { color: ACCENT2, width: 1 } });
  s.addShape(prs.ShapeType.rect, { x: 5.15, y: 0.85, w: 4.65, h: 0.4, fill: { color: ACCENT2, transparency: 25 } });
  s.addShape(prs.ShapeType.rect, { x: 5.15, y: 0.85, w: 0.07, h: 0.4, fill: { color: ACCENT2 } });
  s.addText("LONG-TERM GOALS  (3–6 Months)", { x: 5.3, y: 0.85, w: 4.4, h: 0.4, fontSize: 10, bold: true, color: WHITE, valign: "middle", charSpacing: 1, margin: 0 });
  const lt = ["Achieve PASI-75 or PASI-90 response", "Prevent future flare-ups", "Improve quality of life", "Maintain long-term disease control", "Minimize treatment-related toxicity"];
  lt.forEach((g, i) => {
    const ry = 1.35 + i * 0.5;
    s.addShape(prs.ShapeType.ellipse, { x: 5.3, y: ry + 0.08, w: 0.22, h: 0.22, fill: { color: ACCENT2 } });
    s.addText(`${i + 1}`, { x: 5.3, y: ry + 0.08, w: 0.22, h: 0.22, fontSize: 8, bold: true, color: WHITE, align: "center", valign: "middle", margin: 0 });
    s.addText(g, { x: 5.6, y: ry, w: 4.1, h: 0.4, fontSize: 10, color: LIGHT_TEXT, valign: "middle" });
  });

  // Non-pharm label at bottom
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 4.3, w: 9.6, h: 0.75, fill: { color: MID_BG }, line: { color: ACCENT, width: 0.75 } });
  s.addText("NON-PHARMACOLOGICAL TREATMENT", { x: 0.35, y: 4.3, w: 4, h: 0.35, fontSize: 9, bold: true, color: ACCENT, valign: "middle", charSpacing: 2, margin: 0 });
  const npt = ["Regular moisturization (emollients 3-4×/day)", "Lukewarm water bathing", "Stress management (yoga, meditation)", "Avoid skin trauma & Koebner phenomenon", "Stop smoking, limit alcohol, exercise regularly"];
  s.addText(npt.join("   •   "), { x: 0.35, y: 4.65, w: 9.3, h: 0.32, fontSize: 8.5, color: LIGHT_TEXT });

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 7  |  Planning – Therapeutic Goals", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 8 – PHARMACOLOGICAL TREATMENT TABLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("PHARMACOLOGICAL TREATMENT", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  const rxData = [
    ["1", "Inj. Secukinumab", "300 mg", "SC", "Wks 0,1,2,3,4 → q4w", "Long-term maintenance"],
    ["2", "Tab. Cyclosporine", "75 mg", "PO", "Twice daily", "4–8 wks → taper"],
    ["3", "Clobetasol 0.05% Oint.", "–", "Topical", "Twice daily", "2–4 weeks"],
    ["4", "Clobetasol 0.05% Scalp Sol.", "–", "Topical", "Once daily", "2–4 weeks"],
    ["5", "Calcipotriol 0.005% Oint.", "–", "Topical", "Twice daily", "Long-term maintenance"],
    ["6", "Tab. Cetirizine", "10 mg", "PO", "Once daily (bedtime)", "2–4 wks (until resolved)"],
    ["7", "Emollients/Moisturizers", "–", "Topical", "3–4 times daily", "Continuous"],
  ];

  // Table header
  const cols = ["#", "DRUG", "DOSE", "ROA", "FREQUENCY", "DURATION"];
  const cw = [0.35, 2.5, 0.7, 0.6, 2.4, 2.7];
  const startX = 0.2;
  let cx = startX;

  s.addShape(prs.ShapeType.rect, { x: startX, y: 0.85, w: 9.6, h: 0.4, fill: { color: TABLE_HDR } });
  cols.forEach((c, ci) => {
    s.addText(c, { x: cx + 0.05, y: 0.85, w: cw[ci], h: 0.4, fontSize: 8.5, bold: true, color: ACCENT, valign: "middle", margin: 0 });
    cx += cw[ci];
  });

  const rowColors = [TABLE_ROW1, TABLE_ROW2];
  const rowAccents = [ACCENT, ACCENT2, "#4CAF50", "#4CAF50", "#3AB4F2", "#F9A825", "#8BC34A"];
  rxData.forEach((row, ri) => {
    const ry = 1.25 + ri * 0.54;
    s.addShape(prs.ShapeType.rect, { x: startX, y: ry, w: 9.6, h: 0.52, fill: { color: rowColors[ri % 2] } });
    // left accent
    s.addShape(prs.ShapeType.rect, { x: startX, y: ry, w: 0.04, h: 0.52, fill: { color: rowAccents[ri] } });
    let rcx = startX;
    row.forEach((cell, ci) => {
      const textCol = ci === 1 ? WHITE : LIGHT_TEXT;
      const bold = ci === 0 || ci === 1;
      s.addText(cell, { x: rcx + 0.07, y: ry, w: cw[ci] - 0.07, h: 0.52, fontSize: ci === 1 ? 9 : 8.5, bold, color: textCol, valign: "middle", margin: 0 });
      rcx += cw[ci];
    });
  });

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 8  |  Pharmacological Treatment Plan", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 9 – MONITORING PARAMETERS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("MONITORING PARAMETERS", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  // Efficacy
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 4.55, h: 2.5, fill: { color: CARD_BG }, line: { color: GREEN_OK, width: 1 } });
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 4.55, h: 0.4, fill: { color: GREEN_OK, transparency: 30 } });
  s.addText("EFFICACY MONITORING", { x: 0.35, y: 0.85, w: 4.2, h: 0.4, fontSize: 10, bold: true, color: WHITE, valign: "middle", margin: 0 });
  const eff = ["Reduction in redness (erythema)", "Reduction in scaling", "Reduction in itching (pruritus)", "Decrease in plaque thickness", "Improvement in BSA and PASI score", "Fewer flare-ups, better quality of life"];
  eff.forEach((e, i) => {
    s.addText("✓  " + e, { x: 0.35, y: 1.33 + i * 0.33, w: 4.2, h: 0.3, fontSize: 9, color: LIGHT_TEXT, margin: 0 });
  });

  // Safety - Cyclosporine
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 0.85, w: 4.75, h: 1.4, fill: { color: CARD_BG }, line: { color: ACCENT2, width: 1 } });
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 0.85, w: 4.75, h: 0.38, fill: { color: ACCENT2, transparency: 30 } });
  s.addText("CYCLOSPORINE – Safety", { x: 5.12, y: 0.85, w: 4.5, h: 0.38, fontSize: 9.5, bold: true, color: WHITE, valign: "middle", margin: 0 });
  const cyclo = ["Blood pressure", "Serum creatinine (SCr)", "BUN, electrolytes (K⁺)", "Uric acid levels"];
  cyclo.forEach((c, i) => {
    s.addText("⚠  " + c, { x: 5.12, y: 1.3 + i * 0.3, w: 4.5, h: 0.28, fontSize: 9, color: LIGHT_TEXT, margin: 0 });
  });

  // Safety - Secukinumab
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 2.38, w: 4.75, h: 1.35, fill: { color: CARD_BG }, line: { color: ACCENT, width: 1 } });
  s.addShape(prs.ShapeType.rect, { x: 5.0, y: 2.38, w: 4.75, h: 0.38, fill: { color: MID_BG } });
  s.addText("SECUKINUMAB (Biologic) – Safety", { x: 5.12, y: 2.38, w: 4.5, h: 0.38, fontSize: 9.5, bold: true, color: ACCENT, valign: "middle", margin: 0 });
  const seku = ["Signs of infection; TB screening pre-treatment", "CBC, LFT, RFT periodically"];
  seku.forEach((c, i) => {
    s.addText("⚠  " + c, { x: 5.12, y: 2.82 + i * 0.3, w: 4.5, h: 0.28, fontSize: 9, color: LIGHT_TEXT, margin: 0 });
  });
  s.addText("Topical Corticosteroids: skin atrophy, striae, irritation", { x: 5.12, y: 3.42, w: 4.5, h: 0.28, fontSize: 9, color: LIGHT_TEXT, margin: 0 });

  // Follow-up band
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 3.5, w: 4.55, h: 0.72, fill: { color: CARD_BG }, line: { color: ACCENT, width: 0.75 } });
  s.addText("FOLLOW-UP", { x: 0.35, y: 3.5, w: 2, h: 0.3, fontSize: 9, bold: true, color: ACCENT2, margin: 0 });
  s.addText("Review every 4–8 weeks to assess treatment response and adverse effects", { x: 0.35, y: 3.82, w: 4.2, h: 0.35, fontSize: 9, color: LIGHT_TEXT, margin: 0 });

  // PASI timeline note
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 4.35, w: 9.6, h: 0.78, fill: { color: MID_BG } });
  s.addText("Target: PASI-75 by Week 16  |  PASI-90 by Month 6  |  Sustained PASI-90 for long-term maintenance", {
    x: 0.35, y: 4.35, w: 9.3, h: 0.78, fontSize: 10, bold: true, color: WHITE, align: "center", valign: "middle"
  });

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 9  |  Monitoring Parameters", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 10 – PATIENT COUNSELLING
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  addBg(s, ACCENT);
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 10, h: 0.65, fill: { color: MID_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0.07, w: 0.08, h: 0.65, fill: { color: ACCENT2 } });
  s.addText("PATIENT COUNSELLING", { x: 0.18, y: 0.07, w: 9, h: 0.65, fontSize: 13, bold: true, color: ACCENT, valign: "middle", charSpacing: 3, margin: 0 });

  // Disease education card
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 9.6, h: 1.05, fill: { color: CARD_BG }, line: { color: ACCENT, width: 0.75 } });
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 0.85, w: 9.6, h: 0.35, fill: { color: MID_BG } });
  s.addText("DISEASE EDUCATION", { x: 0.35, y: 0.85, w: 9, h: 0.35, fontSize: 9, bold: true, color: ACCENT, valign: "middle", charSpacing: 2, margin: 0 });
  const edu = ["Psoriasis is a chronic autoimmune skin disease — NOT contagious.", "Treatment controls symptoms and prevents flares; it does not permanently cure the disease."];
  edu.forEach((e, i) => {
    s.addText("•  " + e, { x: 0.35, y: 1.25 + i * 0.3, w: 9.2, h: 0.28, fontSize: 9, color: LIGHT_TEXT, margin: 0 });
  });

  // 3 medication cards
  const meds = [
    {
      name: "Cyclosporine", color: ACCENT2,
      points: ["Take regularly as prescribed", "Avoid grapefruit juice (↑ drug levels)", "Report reduced urine output or swelling", "Monitor BP regularly at home"]
    },
    {
      name: "Secukinumab (Biologic)", color: ACCENT,
      points: ["Store in refrigerator (2–8°C)", "Rotate injection site each time", "Report fever, cough, signs of infection", "Do not miss doses — follow schedule"]
    },
    {
      name: "Topical Steroids", color: GREEN_OK,
      points: ["Apply thin layer to affected areas only", "Do not use longer than prescribed", "Wash hands after application", "Do not apply to face unless directed"]
    }
  ];

  meds.forEach((m, i) => {
    const x = 0.2 + i * 3.27;
    s.addShape(prs.ShapeType.rect, { x, y: 2.07, w: 3.1, h: 2.05, fill: { color: CARD_BG }, line: { color: m.color, width: 1 } });
    s.addShape(prs.ShapeType.rect, { x, y: 2.07, w: 3.1, h: 0.38, fill: { color: m.color, transparency: 25 } });
    s.addText(m.name, { x: x + 0.1, y: 2.07, w: 2.9, h: 0.38, fontSize: 9.5, bold: true, color: WHITE, valign: "middle", margin: 0 });
    m.points.forEach((p, pi) => {
      s.addText("→  " + p, { x: x + 0.1, y: 2.5 + pi * 0.4, w: 2.9, h: 0.38, fontSize: 8.5, color: LIGHT_TEXT, valign: "middle", margin: 0 });
    });
  });

  // Lifestyle row
  s.addShape(prs.ShapeType.rect, { x: 0.2, y: 4.27, w: 9.6, h: 0.8, fill: { color: MID_BG } });
  s.addText("LIFESTYLE COUNSELLING", { x: 0.35, y: 4.27, w: 3, h: 0.3, fontSize: 9, bold: true, color: ACCENT, margin: 0 });
  s.addText("Use moisturizers daily  •  Avoid scratching lesions  •  Manage stress (yoga, sleep)  •  Stop smoking  •  Limit alcohol", {
    x: 0.35, y: 4.57, w: 9.3, h: 0.47, fontSize: 9, color: LIGHT_TEXT, valign: "middle"
  });

  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.35, w: 10, h: 0.28, fill: { color: MID_BG } });
  s.addText("Slide 10  |  Patient Counselling", { x: 0, y: 5.35, w: 10, h: 0.28, fontSize: 8, color: ACCENT, align: "center", valign: "middle" });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 11 – THANK YOU / CONCLUSION
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0, w: 10, h: 5.625, fill: { color: DARK_BG } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 0, w: 10, h: 0.06, fill: { color: ACCENT } });
  s.addShape(prs.ShapeType.rect, { x: 0, y: 5.565, w: 10, h: 0.06, fill: { color: ACCENT } });

  // Decorative half-circle
  s.addShape(prs.ShapeType.ellipse, { x: -2, y: 0.5, w: 6, h: 6, fill: { color: MID_BG, transparency: 60 } });
  s.addShape(prs.ShapeType.ellipse, { x: 6.5, y: -0.5, w: 5, h: 5, fill: { color: ACCENT2, transparency: 85 } });

  s.addText("Thank You", { x: 1, y: 1.0, w: 8, h: 1.2, fontSize: 48, bold: true, color: WHITE, align: "center" });
  s.addShape(prs.ShapeType.line, { x: 2.5, y: 2.25, w: 5, h: 0, line: { color: ACCENT2, width: 2 } });
  s.addText("Questions & Discussion", { x: 1, y: 2.4, w: 8, h: 0.5, fontSize: 16, color: LIGHT_TEXT, align: "center", italic: true });

  // Summary box
  s.addShape(prs.ShapeType.rect, { x: 1.2, y: 3.0, w: 7.6, h: 1.5, fill: { color: CARD_BG }, line: { color: ACCENT, width: 1 } });
  s.addText("Case Summary", { x: 1.4, y: 3.05, w: 7.2, h: 0.35, fontSize: 10, bold: true, color: ACCENT, charSpacing: 2 });
  s.addText("50M | Severe Plaque Psoriasis | 27-yr history | Multiple therapy failures | Recommended: Secukinumab (biologic) + Bridge cyclosporine + Topical agents + Cetirizine + Emollients", {
    x: 1.4, y: 3.4, w: 7.2, h: 1.0, fontSize: 9, color: LIGHT_TEXT, italic: true
  });

  s.addText("Ganavi C  |  V Pharm D  |  21Q0275", { x: 1, y: 4.65, w: 8, h: 0.35, fontSize: 10, color: ACCENT2, align: "center" });
}

// ─── WRITE FILE ───────────────────────────────────────────────────
prs.writeFile({ fileName: "/home/daytona/workspace/plaque-psoriasis-ppt/Plaque_Psoriasis_Case_Professional.pptx" })
  .then(() => console.log("SUCCESS: File written"))
  .catch(e => { console.error("ERROR:", e); process.exit(1); });

Running Command

cd /home/daytona/workspace/plaque-psoriasis-ppt && node build.js 2>&1

Running Command

ls -lh /home/daytona/workspace/plaque-psoriasis-ppt/

Your professional presentation is ready! Here's the download link:

Plaque Psoriasis Case Professional

Presentation · PPTX

What was built - 11 slides with a deep navy/blue medical theme:

Slide	Content
1	Title slide - Bold layout with presenter details (Ganavi C, V Pharm D, 21Q0275), disease tags (Severe, Chronic, Uncontrolled, Biologic Candidate)
2	Subjective - Patient Profile - Info table, chief complaint highlight, social & family history
3	HPI Timeline - 6-card visual timeline from age 23 to current 3rd severe flare
4	Objective Data - Vital sign metric cards + skin exam findings (location grid + characteristics)
5	Laboratory Data - Color-coded tables for CBC, RFT, LFT, Electrolytes & Others (with low-value flags)
6	Assessment - Primary diagnosis highlighted in red, PASI/BSA metrics, Drug Therapy Problems
7	Planning - Goals - Short-term (4-8 wks) vs Long-term (3-6 months) side-by-side + non-pharm treatment
8	Pharmacological Treatment - Full 7-drug table (Secukinumab, Cyclosporine, Clobetasol, Calcipotriol, Cetirizine, Emollients)
9	Monitoring Parameters - Efficacy + safety cards with PASI target timeline
10	Patient Counselling - Disease education + 3 medication cards + lifestyle counselling
11	Thank You / Conclusion - Case summary + discussion

Provide light background and create ppt with the headline font size 28 and subline in 24

Let me check if there's new content in the newly uploaded file first.

Running Command

python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/workspace/attachments/d5c14b05-c595-4513-9bc8-0a6ea537f76f/Plaque Psoriasis Case Study.pptx') print(f'Total slides: {len(prs.slides)}') for i, slide in enumerate(prs.slides): print(f'=== SLIDE {i+1} ===') for shape in slide.shapes: if hasattr(shape, 'text') and shape.text.strip(): print(f' [{shape.shape_type}] {repr(shape.text[:600])}') if shape.has_table if hasattr(shape, 'has_table') else False: tbl = shape.table print(f' TABLE: {len(tbl.rows)} rows x {len(tbl.columns)} cols') for row in tbl.rows: print(' ', [c.text.strip() for c in row.cells]) print() " 2>&1

Running Command

pip install python-pptx -q && python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/workspace/attachments/d5c14b05-c595-4513-9bc8-0a6ea537f76f/Plaque Psoriasis Case Study.pptx') print(f'Total slides: {len(prs.slides)}') for i, slide in enumerate(prs.slides): print(f'=== SLIDE {i+1} ===') for shape in slide.shapes: if hasattr(shape, 'text') and shape.text.strip(): print(f' [{shape.shape_type}] {repr(shape.text[:600])}') try: if shape.has_table: tbl = shape.table print(f' TABLE: {len(tbl.rows)} rows x {len(tbl.columns)} cols') for row in tbl.rows: print(' ', [c.text.strip() for c in row.cells]) except: pass print() " 2>&1 | tail -120

Running Command

python3 -c " from pptx import Presentation prs = Presentation('/home/daytona/workspace/attachments/d5c14b05-c595-4513-9bc8-0a6ea537f76f/Plaque Psoriasis Case Study.pptx') for i, slide in enumerate(prs.slides): print(f'=== SLIDE {i+1} ===') for shape in slide.shapes: if hasattr(shape, 'text') and shape.text.strip(): print(f' [{shape.shape_type}] {repr(shape.text[:600])}') try: if shape.has_table: tbl = shape.table print(f' TABLE: {len(tbl.rows)} rows x {len(tbl.columns)} cols') for row in tbl.rows: print(' ', [c.text.strip() for c in row.cells]) except: pass print() " 2>&1 | head -120

I have all the content - 17 slides with richer detail. Now I'll build the full light-background professional PPT with headline at 28pt and sublines at 24pt.

Writing File

~/plaque-psoriasis-ppt/build_light.js

const pptxgen = require("pptxgenjs");

const prs = new pptxgen();
prs.layout = "LAYOUT_16x9";
prs.title = "Plaque Psoriasis Case Study";
prs.author = "Ganavi C";

// ─── LIGHT COLOUR PALETTE ──────────────────────────────────────────
const BG          = "F5F7FA";   // near-white page background
const WHITE       = "FFFFFF";
const NAVY        = "1A3557";   // primary dark text / header bars
const TEAL        = "0D7377";   // accent 1 (teal)
const CORAL       = "E05A2B";   // accent 2 (warm coral)
const LIGHT_TEAL  = "E8F5F5";   // card fill
const LIGHT_CORAL = "FEF0EA";   // card fill alt
const LIGHT_NAVY  = "EBF0F7";   // section band fill
const MID_GRAY    = "5A6A7A";   // body text
const LIGHT_GRAY  = "DDE3EA";   // table alt row / borders
const GREEN       = "2E7D32";
const RED         = "C62828";
const AMBER       = "F57F17";

// Sizes
const HEAD  = 28;   // headline
const SUB   = 24;   // sub-headline / section header
const BODY  = 11;
const SMALL = 9.5;

// ─── Helpers ───────────────────────────────────────────────────────
function bg(slide) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:0, w:10, h:5.625, fill:{ color: BG } });
}

function footer(slide, num, label) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:5.43, w:10, h:0.195, fill:{ color: NAVY } });
  slide.addText(`Slide ${num}  ·  ${label}`, {
    x:0.2, y:5.43, w:9.6, h:0.195,
    fontSize:8, color:"AECBEA", valign:"middle", margin:0
  });
  slide.addText("Plaque Psoriasis Case  |  Ganavi C  |  V Pharm D  |  21Q0275", {
    x:0, y:5.43, w:9.8, h:0.195,
    fontSize:8, color:"AECBEA", align:"right", valign:"middle", margin:0
  });
}

function titleBar(slide, headline, sub) {
  // Solid header strip
  slide.addShape(prs.ShapeType.rect, { x:0, y:0, w:10, h:1.05, fill:{ color: NAVY } });
  slide.addShape(prs.ShapeType.rect, { x:0, y:1.05, w:10, h:0.05, fill:{ color: TEAL } });
  slide.addText(headline, {
    x:0.35, y:0.05, w:9.3, h:0.6,
    fontSize: HEAD, bold:true, color: WHITE, valign:"bottom", margin:0
  });
  if (sub) {
    slide.addText(sub, {
      x:0.35, y:0.65, w:9.3, h:0.38,
      fontSize: SUB, color:"AECBEA", valign:"top", margin:0, italic:true
    });
  }
}

function card(slide, x, y, w, h, title, titleColor, fillColor, borderColor) {
  slide.addShape(prs.ShapeType.rect, {
    x, y, w, h, fill:{ color: fillColor || LIGHT_TEAL },
    line:{ color: borderColor || TEAL, width:1 }
  });
  if (title) {
    slide.addShape(prs.ShapeType.rect, { x, y, w, h:0.36, fill:{ color: titleColor || TEAL } });
    slide.addText(title, {
      x: x+0.12, y, w: w-0.2, h:0.36,
      fontSize: SMALL+1, bold:true, color: WHITE, valign:"middle", margin:0
    });
  }
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 1 – TITLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  // Two-tone background
  s.addShape(prs.ShapeType.rect, { x:0, y:0, w:10, h:5.625, fill:{ color: WHITE } });
  s.addShape(prs.ShapeType.rect, { x:0, y:0, w:4.2, h:5.625, fill:{ color: NAVY } });
  s.addShape(prs.ShapeType.rect, { x:4.2, y:0, w:0.07, h:5.625, fill:{ color: TEAL } });

  // Decorative circles on navy side
  s.addShape(prs.ShapeType.ellipse, { x:-0.9, y:-0.9, w:3.5, h:3.5, fill:{ color: TEAL, transparency:80 } });
  s.addShape(prs.ShapeType.ellipse, { x:0.3, y:3.8, w:2.5, h:2.5, fill:{ color: CORAL, transparency:82 } });

  // Left panel
  s.addText("CASE\nSTUDY", {
    x:0.2, y:0.55, w:3.7, h:1.5,
    fontSize:38, bold:true, color: WHITE, align:"center", charSpacing:6
  });
  s.addShape(prs.ShapeType.line, { x:0.6, y:2.15, w:2.9, h:0, line:{ color: TEAL, width:2 } });
  s.addText("Dermatology\nClinical Pharmacy", {
    x:0.2, y:2.28, w:3.7, h:0.75,
    fontSize:13, color:"AECBEA", align:"center", italic:true
  });

  // Presenter card
  s.addShape(prs.ShapeType.rect, { x:0.3, y:3.3, w:3.55, h:1.6, fill:{ color:"0D2237" }, line:{ color: TEAL, width:1 } });
  s.addText("PRESENTED BY", { x:0.42, y:3.38, w:3.3, h:0.28, fontSize:8, bold:true, color: TEAL, align:"center", charSpacing:3 });
  s.addText([
    { text:"Ganavi C\n", options:{ bold:true, fontSize:15 } },
    { text:"V Pharm D\n", options:{ fontSize:12 } },
    { text:"Reg No: 21Q0275", options:{ fontSize:11, color:"AECBEA" } }
  ], { x:0.42, y:3.7, w:3.3, h:1.1, color: WHITE, align:"center" });

  // Right panel – main title
  s.addText("Plaque Psoriasis", {
    x:4.5, y:0.65, w:5.3, h:1.0,
    fontSize: HEAD+8, bold:true, color: NAVY
  });
  s.addText("Clinical Case Study", {
    x:4.5, y:1.65, w:5.3, h:0.55,
    fontSize: SUB, color: TEAL, italic:true
  });
  s.addShape(prs.ShapeType.line, { x:4.5, y:2.28, w:5.0, h:0, line:{ color: CORAL, width:2 } });

  // Tag chips
  const tags = ["Severe","Chronic","Uncontrolled","Biologic Candidate"];
  tags.forEach((t, i) => {
    s.addShape(prs.ShapeType.roundRect, { x:4.5+i*1.3, y:2.42, w:1.22, h:0.32, fill:{ color: LIGHT_CORAL }, line:{ color: CORAL, width:1 }, rectRadius:0.04 });
    s.addText(t, { x:4.5+i*1.3, y:2.42, w:1.22, h:0.32, fontSize:8, bold:true, color: CORAL, align:"center", valign:"middle", margin:0 });
  });

  s.addText(
    "A 50-year-old male with a 27-year history of plaque psoriasis\npresenting with severe, uncontrolled disease despite multiple lines of therapy.",
    { x:4.5, y:2.9, w:5.3, h:0.9, fontSize:11, color: MID_GRAY, italic:true }
  );

  // Bottom strip
  s.addShape(prs.ShapeType.rect, { x:0, y:5.43, w:10, h:0.195, fill:{ color: LIGHT_GRAY } });
  s.addText("V Pharm D  ·  Clinical Pharmacy Case Presentation  ·  2024", {
    x:0, y:5.43, w:10, h:0.195, fontSize:8.5, color: MID_GRAY, align:"center", valign:"middle"
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 2 – PATIENT PROFILE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "SUBJECTIVE DATA", "Patient Profile");
  footer(s, 2, "Subjective Data – Patient Profile");

  // Patient info table
  card(s, 0.25, 1.18, 4.5, 3.35, "PATIENT INFORMATION", NAVY, LIGHT_NAVY, NAVY);
  const patRows = [
    ["Age","50 years"], ["Gender","Male"],
    ["Occupation","Elementary School Teacher"],
    ["Weight","75 kg"], ["Height","5'9\""], ["Allergies","NKA"]
  ];
  patRows.forEach(([k,v], i) => {
    const ry = 1.6 + i*0.47;
    const fill = i%2===0 ? WHITE : LIGHT_NAVY;
    s.addShape(prs.ShapeType.rect, { x:0.25, y:ry, w:4.5, h:0.44, fill:{ color:fill } });
    s.addText(k, { x:0.38, y:ry, w:1.8, h:0.44, fontSize:SMALL+0.5, bold:true, color:NAVY, valign:"middle", margin:0 });
    s.addText(v, { x:2.2, y:ry, w:2.42, h:0.44, fontSize:SMALL+0.5, color:MID_GRAY, valign:"middle", margin:0 });
  });

  // Chief complaint
  s.addShape(prs.ShapeType.rect, { x:5.0, y:1.18, w:4.75, h:1.1, fill:{ color: LIGHT_CORAL }, line:{ color: CORAL, width:1.5 } });
  s.addText("CHIEF COMPLAINT", { x:5.15, y:1.22, w:4.45, h:0.3, fontSize:SMALL, bold:true, color:CORAL, charSpacing:2, margin:0 });
  s.addText('"Nothing is helping my psoriasis."', {
    x:5.15, y:1.52, w:4.45, h:0.68,
    fontSize:14, color:NAVY, italic:true, valign:"middle"
  });

  // Note
  s.addShape(prs.ShapeType.rect, { x:5.0, y:2.42, w:4.75, h:2.11, fill:{ color: LIGHT_TEAL }, line:{ color: TEAL, width:1 } });
  s.addText("CLINICAL NOTE", { x:5.15, y:2.48, w:4.45, h:0.3, fontSize:SMALL, bold:true, color:TEAL, charSpacing:2, margin:0 });
  s.addText(
    "Subjective input emphasizes significant mental burden and clinical therapeutic non-response to conventional routes. Patient presents with clear frustration after years of escalating treatment without adequate disease control.",
    { x:5.15, y:2.82, w:4.45, h:1.65, fontSize:SMALL+0.5, color:MID_GRAY }
  );
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 3 – HPI TIMELINE PART 1
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "HISTORY OF PRESENT ILLNESS", "27-Year Treatment Chronology (Part 1)");
  footer(s, 3, "HPI – Treatment Timeline Part 1");

  s.addText("Chronological course of medical interventions since early diagnosis:", {
    x:0.3, y:1.18, w:9.4, h:0.3, fontSize:SMALL+1, color:MID_GRAY, italic:true
  });

  const events = [
    { label:"Initial Diagnosis", age:"Age 23", color: TEAL, bg: LIGHT_TEAL,
      text:"Plaque psoriasis diagnosed. Initially achieved good control with medium-potency topical corticosteroids." },
    { label:"Combination Course", age:"Mid-course", color: NAVY, bg: LIGHT_NAVY,
      text:"Calcipotriol therapy added when topical corticosteroids alone became insufficient for disease control." },
    { label:"Phototherapy Run", age:"Disease progression", color:"6A5ACD", bg:"F0EEF9",
      text:"PUVA (Psoralen + UVA) phototherapy initiated — provided temporary improvement." },
    { label:"Efficacy Loss", age:"Later", color: CORAL, bg: LIGHT_CORAL,
      text:"PUVA gradually lost effectiveness, resulting in inadequate disease control and recurrent lesions." },
  ];

  events.forEach((e, i) => {
    const x = 0.25 + (i%2)*4.9;
    const y = i < 2 ? 1.58 : 3.2;
    s.addShape(prs.ShapeType.rect, { x, y, w:4.6, h:1.48, fill:{ color:e.bg }, line:{ color:e.color, width:1.5 } });
    s.addShape(prs.ShapeType.rect, { x, y, w:4.6, h:0.42, fill:{ color:e.color } });
    s.addText(e.label, { x:x+0.12, y, w:3.0, h:0.42, fontSize:SMALL+1.5, bold:true, color:WHITE, valign:"middle", margin:0 });
    s.addText(e.age, { x:x+3.1, y, w:1.38, h:0.42, fontSize:SMALL, color:WHITE, align:"right", valign:"middle", margin:0 });
    s.addText(e.text, { x:x+0.12, y:y+0.48, w:4.35, h:0.96, fontSize:SMALL+0.5, color:MID_GRAY, valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 4 – HPI TIMELINE PART 2
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "HISTORY OF PRESENT ILLNESS", "27-Year Treatment Chronology (Part 2)");
  footer(s, 4, "HPI – Treatment Timeline Part 2");

  const events = [
    { label:"Systemic Methotrexate Escalation", color: NAVY, bg: LIGHT_NAVY,
      text1:"Frequent psoriasis flare-ups despite increasing methotrexate doses, requiring short-contact anthralin therapy (SCAT) for acute exacerbations.",
      text2:"Methotrexate escalated to 25 mg/week — cumulative lifetime dose: 2.2 g." },
    { label:"Switch to Cyclosporine + Acitretin", color: TEAL, bg: LIGHT_TEAL,
      text1:"Treatment changed to cyclosporine 75 mg twice daily + acitretin 25 mg daily.",
      text2:"Acitretin discontinued due to severe xerosis." },
    { label:"Acitretin Intolerance & Current Flare", color: CORAL, bg: LIGHT_CORAL,
      text1:"Cyclosporine alone provided good control for 1 year.",
      text2:"Last 6 months: two severe flare-ups. Current presentation = 3rd and most severe flare." },
  ];

  events.forEach((e, i) => {
    const y = 1.22 + i*1.35;
    s.addShape(prs.ShapeType.rect, { x:0.25, y, w:9.5, h:1.22, fill:{ color:e.bg }, line:{ color:e.color, width:1.5 } });
    s.addShape(prs.ShapeType.rect, { x:0.25, y, w:9.5, h:0.4, fill:{ color:e.color } });
    s.addText(`${i+1}. ${e.label}`, { x:0.4, y, w:9.1, h:0.4, fontSize:11, bold:true, color:WHITE, valign:"middle", margin:0 });
    s.addText("•  " + e.text1, { x:0.4, y:y+0.44, w:4.55, h:0.73, fontSize:SMALL+0.5, color:MID_GRAY, valign:"top" });
    s.addText("•  " + e.text2, { x:5.1, y:y+0.44, w:4.5, h:0.73, fontSize:SMALL+0.5, color:MID_GRAY, valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 5 – MEDICAL / FAMILY / SOCIAL HISTORY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "MEDICAL, FAMILY & SOCIAL HISTORY", "Background & Risk Factors");
  footer(s, 5, "Medical / Family / Social History");

  // Med & Family
  card(s, 0.25, 1.18, 4.5, 2.3, "MEDICAL & FAMILY HISTORY", NAVY, LIGHT_NAVY, NAVY);
  const mfRows = [
    ["PMH","Major depressive episode — 16 years ago"],
    ["Brother","Has psoriasis"],
    ["Father","Hypertension + Type 2 Diabetes"],
  ];
  mfRows.forEach(([k,v], i) => {
    const ry = 1.6 + i*0.58;
    s.addShape(prs.ShapeType.rect, { x:0.25, y:ry, w:4.5, h:0.54, fill:{ color: i%2===0?WHITE:LIGHT_NAVY } });
    s.addText(k, { x:0.38, y:ry, w:1.1, h:0.54, fontSize:SMALL, bold:true, color:NAVY, valign:"middle", margin:0 });
    s.addText(v, { x:1.5, y:ry, w:3.1, h:0.54, fontSize:SMALL+0.5, color:MID_GRAY, valign:"middle" });
  });

  // Social
  card(s, 5.0, 1.18, 4.75, 2.3, "SOCIAL PROFILE & TRIGGERS", TEAL, LIGHT_TEAL, TEAL);
  const socRows = [
    ["Smoking","Former heavy smoker"],
    ["Alcohol","One glass of wine daily"],
    ["Stress","Increased occupational stress"],
    ["Family","Married with children"],
  ];
  socRows.forEach(([k,v], i) => {
    const ry = 1.6 + i*0.47;
    s.addShape(prs.ShapeType.rect, { x:5.0, y:ry, w:4.75, h:0.43, fill:{ color: i%2===0?WHITE:LIGHT_TEAL } });
    s.addText(k, { x:5.12, y:ry, w:1.2, h:0.43, fontSize:SMALL, bold:true, color:TEAL, valign:"middle", margin:0 });
    s.addText(v, { x:6.35, y:ry, w:3.25, h:0.43, fontSize:SMALL+0.5, color:MID_GRAY, valign:"middle" });
  });

  // Allergies
  card(s, 0.25, 3.62, 4.5, 1.0, "ALLERGIES & TOLERABILITY", CORAL, LIGHT_CORAL, CORAL);
  s.addText([
    { text:"NKA  ", options:{ bold:true, color:GREEN } },
    { text:"(No Known Allergies)", options:{} }
  ], { x:0.38, y:4.02, w:4.2, h:0.26, fontSize:SMALL+1, color:MID_GRAY });
  s.addText("Drug intolerance: Acitretin — confirmed severe xerosis", { x:0.38, y:4.3, w:4.2, h:0.26, fontSize:SMALL, color:MID_GRAY });

  // Smoking/alcohol risk note
  card(s, 5.0, 3.62, 4.75, 1.0, "RISK AMPLIFIERS", CORAL, LIGHT_CORAL, CORAL);
  s.addText("Smoking, alcohol, and occupational stress are well-established triggers for psoriasis flares and may contribute to treatment resistance.", {
    x:5.12, y:4.02, w:4.5, h:0.55, fontSize:SMALL+0.5, color:MID_GRAY
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 6 – OBJECTIVE: VITALS & SKIN EXAM
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "OBJECTIVE DATA", "Vital Signs & Physical Examination");
  footer(s, 6, "Objective Data – Vitals & Skin Exam");

  // Vital metric boxes
  const vitals = [
    { label:"BLOOD PRESSURE", val:"129/83", unit:"mmHg", col: NAVY },
    { label:"PULSE RATE",     val:"88",     unit:"bpm",  col: TEAL },
    { label:"TEMPERATURE",   val:"37°C",   unit:"Normal", col:"6A5ACD" },
    { label:"APPEARANCE",    val:"Alert",  unit:"Mild anxiety", col: CORAL },
  ];
  vitals.forEach((v, i) => {
    const x = 0.25 + i*2.42;
    s.addShape(prs.ShapeType.rect, { x, y:1.18, w:2.3, h:1.25, fill:{ color: WHITE }, line:{ color: v.col, width:2 } });
    s.addShape(prs.ShapeType.rect, { x, y:1.18, w:2.3, h:0.35, fill:{ color: v.col } });
    s.addText(v.label, { x:x+0.07, y:1.18, w:2.16, h:0.35, fontSize:7.5, bold:true, color:WHITE, valign:"middle", margin:0 });
    s.addText(v.val,  { x:x+0.07, y:1.55, w:2.16, h:0.52, fontSize:22, bold:true, color:v.col, align:"center" });
    s.addText(v.unit, { x:x+0.07, y:2.07, w:2.16, h:0.32, fontSize:SMALL, color:MID_GRAY, align:"center" });
  });

  // Skin examination card
  s.addShape(prs.ShapeType.rect, { x:0.25, y:2.57, w:9.5, h:2.62, fill:{ color: WHITE }, line:{ color: RED, width:1.5 } });
  s.addShape(prs.ShapeType.rect, { x:0.25, y:2.57, w:9.5, h:0.4, fill:{ color: RED } });
  s.addText("SKIN EXAMINATION — Severe Plaque Psoriasis", {
    x:0.4, y:2.57, w:9.15, h:0.4, fontSize:11, bold:true, color:WHITE, valign:"middle", charSpacing:1, margin:0
  });

  // Location chips
  const locs = ["Abdomen","Arms","Legs","Back","Scalp","Palms","Soles","Elbows","Knees"];
  s.addText("Affected Locations:", { x:0.4, y:3.03, w:2.0, h:0.3, fontSize:SMALL, bold:true, color:NAVY, margin:0 });
  locs.forEach((loc, i) => {
    const x = 2.35 + i*0.81;
    s.addShape(prs.ShapeType.roundRect, { x, y:3.03, w:0.75, h:0.28, fill:{ color: LIGHT_CORAL }, line:{ color: CORAL, width:0.75 }, rectRadius:0.04 });
    s.addText(loc, { x, y:3.03, w:0.75, h:0.28, fontSize:7.5, bold:true, color: CORAL, align:"center", valign:"middle", margin:0 });
  });

  // Visual + secondary signs
  s.addText("Visual Profile:", { x:0.4, y:3.42, w:1.5, h:0.28, fontSize:SMALL, bold:true, color:NAVY, margin:0 });
  s.addText("Thick plaques  ·  Erythematous lesions  ·  Well-demarcated borders  ·  Confluent lesions", {
    x:1.9, y:3.42, w:7.6, h:0.28, fontSize:SMALL+0.5, color:MID_GRAY, margin:0
  });
  s.addText("Secondary Signs:", { x:0.4, y:3.76, w:1.8, h:0.28, fontSize:SMALL, bold:true, color:NAVY, margin:0 });
  s.addText("Silvery-white scales  ·  Excoriations due to scratching", {
    x:2.2, y:3.76, w:7.3, h:0.28, fontSize:SMALL+0.5, color:MID_GRAY, margin:0
  });
  s.addText("General Status:", { x:0.4, y:4.1, w:1.8, h:0.28, fontSize:SMALL, bold:true, color:NAVY, margin:0 });
  s.addText("Alert, oriented — Mild anxiety noted.", {
    x:2.2, y:4.1, w:7.3, h:0.28, fontSize:SMALL+0.5, color:MID_GRAY, margin:0
  });
}

// ═══════════════════════════════════════════════════════════════════
// HELPER – lab table renderer
// ═══════════════════════════════════════════════════════════════════
function labTable(slide, x, y, w, title, rows) {
  const HDR_H = 0.36;
  const ROW_H = 0.38;
  const totalH = HDR_H * 2 + rows.length * ROW_H;
  slide.addShape(prs.ShapeType.rect, { x, y, w, h: HDR_H, fill:{ color: NAVY } });
  slide.addText(title, { x:x+0.1, y, w:w-0.15, h:HDR_H, fontSize:SMALL+1, bold:true, color:WHITE, valign:"middle", margin:0 });

  const cw = [w*0.44, w*0.28, w*0.28];
  const hdrs = ["Parameter","Result","Normal Range"];
  let cx = x;
  slide.addShape(prs.ShapeType.rect, { x, y:y+HDR_H, w, h:HDR_H, fill:{ color: LIGHT_NAVY } });
  hdrs.forEach((h, ci) => {
    slide.addText(h, { x:cx+0.06, y:y+HDR_H, w:cw[ci]-0.06, h:HDR_H, fontSize:SMALL, bold:true, color:NAVY, valign:"middle", margin:0 });
    cx += cw[ci];
  });

  rows.forEach((row, ri) => {
    const ry = y + HDR_H*2 + ri*ROW_H;
    const fill = ri%2===0 ? WHITE : LIGHT_GRAY;
    slide.addShape(prs.ShapeType.rect, { x, y:ry, w, h:ROW_H, fill:{ color:fill }, line:{ color: LIGHT_GRAY, width:0.5 } });
    let rcx = x;
    const isLow  = row[1].toLowerCase().includes("low") || row[3]==="L";
    const isHigh = row[3]==="H";
    row.slice(0,3).forEach((cell, ci) => {
      let tc = MID_GRAY;
      if (ci===1 && isLow)  tc = AMBER;
      if (ci===1 && isHigh) tc = RED;
      if (ci===0) tc = NAVY;
      slide.addText(cell, { x:rcx+0.06, y:ry, w:cw[ci]-0.06, h:ROW_H, fontSize:SMALL, color:tc, bold:ci===0, valign:"middle", margin:0 });
      rcx += cw[ci];
    });
  });

  return y + HDR_H*2 + rows.length*ROW_H;
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 7 – LAB DATA: CBC & RENAL
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "LABORATORY DATA", "Complete Blood Count & Renal Panel");
  footer(s, 7, "Lab Data – CBC & Renal");

  const cbcRows = [
    ["Hemoglobin (Hb)",    "13.5 g/dL",       "13.5–17.5 g/dL",   "N"],
    ["Hematocrit (Hct)",   "35% (Mildly Low)", "40–52%",           "L"],
    ["WBC",                "6.0 ×10³/mm³",     "4–11 × 10³/mm³",   "N"],
    ["Platelets",          "255 ×10³/mm³",     "150–400 × 10³/mm³","N"],
  ];
  const rftRows = [
    ["Blood Urea Nitrogen (BUN)", "14 mg/dL", "7–20 mg/dL",   "N"],
    ["Creatinine (SCr)",          "1.0 mg/dL","0.6–1.3 mg/dL","N"],
  ];

  labTable(s, 0.25, 1.18, 9.5, "COMPLETE BLOOD COUNT (CBC)", cbcRows);
  labTable(s, 0.25, 3.65, 9.5, "RENAL FUNCTION TEST (RFT)", rftRows);

  // Hct flag note
  s.addShape(prs.ShapeType.rect, { x:0.25, y:5.15, w:9.5, h:0.25, fill:{ color: LIGHT_CORAL }, line:{ color: AMBER, width:0.75 } });
  s.addText("⚠  Hematocrit (35%) is mildly below normal range (40–52%) — may indicate mild anemia. Clinically monitor.", {
    x:0.4, y:5.15, w:9.2, h:0.25, fontSize:8.5, color: AMBER, valign:"middle", margin:0
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 8 – LAB DATA: LIVER FUNCTION
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "LABORATORY DATA", "Liver Function Profile");
  footer(s, 8, "Lab Data – Liver Function");

  const lftRows = [
    ["AST (SGOT)",              "22 IU/L",  "10–40 IU/L",  "N"],
    ["ALT (SGPT)",              "38 IU/L",  "7–56 IU/L",   "N"],
    ["Alkaline Phosphatase (ALP)","98 IU/L","44–147 IU/L", "N"],
    ["Total Bilirubin",         "1.0 mg/dL","0.1–1.2 mg/dL","N"],
    ["Albumin",                 "3.7 g/dL", "3.5–5.0 g/dL","N"],
  ];

  labTable(s, 0.25, 1.18, 9.5, "LIVER FUNCTION TEST (LFT)", lftRows);

  // Interpretation note
  s.addShape(prs.ShapeType.rect, { x:0.25, y:4.05, w:9.5, h:1.1, fill:{ color: LIGHT_TEAL }, line:{ color: TEAL, width:1 } });
  s.addText("CLINICAL INTERPRETATION", { x:0.4, y:4.1, w:9, h:0.3, fontSize:SMALL, bold:true, color:TEAL, charSpacing:2, margin:0 });
  s.addText(
    "All liver function parameters are within normal limits. This is clinically significant as the patient has a history of methotrexate use (cumulative dose 2.2 g), which can cause hepatotoxicity. Normal LFTs support the transition to biologic therapy (Secukinumab).",
    { x:0.4, y:4.42, w:9.1, h:0.68, fontSize:SMALL+0.5, color:MID_GRAY }
  );
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 9 – LAB DATA: ELECTROLYTES & CHEMISTRY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "LABORATORY DATA", "Electrolytes & Chemistry Panel");
  footer(s, 9, "Lab Data – Electrolytes & Chemistry");

  const eRows = [
    ["Sodium (Na⁺)",           "139 mEq/L", "135–145 mEq/L","N"],
    ["Potassium (K⁺)",         "4.0 mEq/L", "3.5–5.0 mEq/L","N"],
    ["Chloride (Cl⁻)",         "102 mEq/L", "98–106 mEq/L", "N"],
    ["Bicarbonate (HCO₃⁻/CO₂)","25 mEq/L",  "22–28 mEq/L",  "N"],
    ["Uric Acid",              "4 mg/dL",   "3.5–7.2 mg/dL","N"],
    ["Total Cholesterol",      "180 mg/dL", "<200 mg/dL",   "N"],
    ["Blood Glucose",          "98 mg/dL",  "70–110 mg/dL", "N"],
  ];

  labTable(s, 0.25, 1.18, 9.5, "ELECTROLYTES & CHEMISTRY", eRows);

  // Cyclosporine note
  s.addShape(prs.ShapeType.rect, { x:0.25, y:4.82, w:9.5, h:0.8, fill:{ color: LIGHT_TEAL }, line:{ color: TEAL, width:1 } });
  s.addText("CYCLOSPORINE SAFETY NOTE", { x:0.4, y:4.87, w:9, h:0.28, fontSize:SMALL, bold:true, color:TEAL, charSpacing:2, margin:0 });
  s.addText("Potassium and renal parameters are within normal limits — important for cyclosporine safety monitoring (hyperkalemia and nephrotoxicity risk).", {
    x:0.4, y:5.15, w:9.1, h:0.42, fontSize:SMALL+0.5, color:MID_GRAY
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 10 – ASSESSMENT: DIAGNOSIS & SEVERITY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "ASSESSMENT", "Diagnosis & Severity Profile");
  footer(s, 10, "Assessment – Diagnosis & Severity");

  // Diagnosis highlight
  s.addShape(prs.ShapeType.rect, { x:0.25, y:1.18, w:9.5, h:0.65, fill:{ color: LIGHT_CORAL }, line:{ color: CORAL, width:2 } });
  s.addText("PRIMARY DIAGNOSIS", { x:0.42, y:1.22, w:3, h:0.28, fontSize:SMALL, bold:true, color:CORAL, charSpacing:2, margin:0 });
  s.addText("Severe Chronic Plaque Psoriasis (Uncontrolled)", {
    x:0.42, y:1.48, w:9, h:0.32, fontSize:14, bold:true, color:NAVY, margin:0
  });

  // Metric boxes
  const metrics = [
    { label:"BSA Involvement", val:">20%",   sub:"Severe threshold: >10%", col: RED },
    { label:"Estimated PASI",  val:">20",    sub:"Severe disease index",    col: CORAL },
    { label:"Disease Duration",val:"27 yrs", sub:"Chronic, refractory",     col: NAVY },
  ];
  metrics.forEach((m, i) => {
    const x = 0.25 + i*3.25;
    s.addShape(prs.ShapeType.rect, { x, y:1.98, w:3.1, h:1.2, fill:{ color: WHITE }, line:{ color: m.col, width:2 } });
    s.addText(m.label, { x:x+0.1, y:2.0, w:2.9, h:0.3, fontSize:SMALL, bold:true, color:m.col, margin:0 });
    s.addText(m.val,   { x:x+0.1, y:2.28, w:2.9, h:0.55, fontSize:28, bold:true, color:m.col, align:"center" });
    s.addText(m.sub,   { x:x+0.1, y:2.83, w:2.9, h:0.28, fontSize:SMALL-0.5, color:MID_GRAY, align:"center" });
  });

  // Evidence & severity area
  s.addShape(prs.ShapeType.rect, { x:0.25, y:3.3, w:4.65, h:1.85, fill:{ color: LIGHT_NAVY }, line:{ color: NAVY, width:1 } });
  s.addText("CLINICAL EVIDENCE", { x:0.4, y:3.34, w:4.3, h:0.3, fontSize:SMALL, bold:true, color:NAVY, charSpacing:2, margin:0 });
  const evidence = [
    "Typical erythematous plaques with silvery scales",
    "Extensive body involvement",
    "Long-standing disease (27 years)",
    "Positive family history of psoriasis",
  ];
  evidence.forEach((e, i) => {
    s.addText("✓  " + e, { x:0.4, y:3.68+i*0.35, w:4.3, h:0.32, fontSize:SMALL+0.5, color:MID_GRAY });
  });

  s.addShape(prs.ShapeType.rect, { x:5.1, y:3.3, w:4.65, h:1.85, fill:{ color: LIGHT_CORAL }, line:{ color: CORAL, width:1 } });
  s.addText("SEVERITY BENCHMARKS", { x:5.25, y:3.34, w:4.3, h:0.3, fontSize:SMALL, bold:true, color:CORAL, charSpacing:2, margin:0 });
  const sev = [
    "BSA Involvement: >20%",
    "Areas: Scalp, Arms, Legs, Abdomen, Back, Palms, Soles",
    "Severity: Severe (>10% BSA)",
    "PASI Score: >20 (Severe disease index)",
  ];
  sev.forEach((e, i) => {
    s.addText("•  " + e, { x:5.25, y:3.68+i*0.35, w:4.3, h:0.32, fontSize:SMALL+0.5, color:MID_GRAY });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 11 – ASSESSMENT: DRUG THERAPY PROBLEMS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "ASSESSMENT", "Drug Therapy Problems (DTPs)");
  footer(s, 11, "Assessment – Drug Therapy Problems");

  const dtps = [
    { num:"DTP 1", title:"Refractory Uncontrolled Status", col: RED,      bg: LIGHT_CORAL,
      text:"Uncontrolled severe plaque psoriasis despite active cyclosporine therapy." },
    { num:"DTP 2", title:"Subtherapeutic Efficacy",        col: CORAL,    bg: LIGHT_CORAL,
      text:"Inadequate physiological response to current cyclosporine dosing regimen." },
    { num:"DTP 3", title:"Historical Failures",            col: AMBER,    bg:"FFF8E1",
      text:"Previous treatment failures: topical therapy, PUVA, and methotrexate." },
    { num:"DTP 4", title:"Adverse Event Intolerance",      col:"6A5ACD",  bg:"F0EEF9",
      text:"Oral acitretin intolerance due to secondary severe xerosis (dry skin)." },
    { num:"DTP 5", title:"Severe Pruritus Burden",         col: TEAL,     bg: LIGHT_TEAL,
      text:"Severe pruritus causing chronic scratching and excoriations on skin." },
    { num:"DTP 6", title:"Psychosocial Exacerbation",      col: NAVY,     bg: LIGHT_NAVY,
      text:"Occupational stress contributing to disease flare-ups and worsening symptoms." },
  ];

  dtps.forEach((d, i) => {
    const x = 0.25 + (i%2)*4.9;
    const y = 1.18 + Math.floor(i/2)*1.4;
    s.addShape(prs.ShapeType.rect, { x, y, w:4.6, h:1.28, fill:{ color:d.bg }, line:{ color:d.col, width:1.5 } });
    s.addShape(prs.ShapeType.rect, { x, y, w:4.6, h:0.4, fill:{ color:d.col } });
    s.addText(d.num, { x:x+0.1, y, w:0.75, h:0.4, fontSize:SMALL, bold:true, color:WHITE, valign:"middle", margin:0 });
    s.addText(d.title, { x:x+0.85, y, w:3.65, h:0.4, fontSize:SMALL+0.5, bold:true, color:WHITE, valign:"middle", margin:0 });
    s.addText(d.text, { x:x+0.12, y:y+0.45, w:4.35, h:0.78, fontSize:SMALL+0.5, color:MID_GRAY, valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 12 – PLANNING: GOALS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "PLANNING", "Goals of Therapy");
  footer(s, 12, "Planning – Goals of Therapy");

  // Short-term
  s.addShape(prs.ShapeType.rect, { x:0.25, y:1.18, w:4.65, h:3.35, fill:{ color: WHITE }, line:{ color: TEAL, width:2 } });
  s.addShape(prs.ShapeType.rect, { x:0.25, y:1.18, w:4.65, h:0.45, fill:{ color: TEAL } });
  s.addText("SHORT-TERM GOALS", { x:0.4, y:1.18, w:3.2, h:0.45, fontSize:SUB-8, bold:true, color:WHITE, valign:"middle", margin:0 });
  s.addText("4–8 Weeks", { x:3.6, y:1.18, w:1.2, h:0.45, fontSize:SMALL, color:"B2EBF2", align:"right", valign:"middle", margin:0 });
  const stGoals = ["Reduce erythema (redness)","Reduce scaling","Relieve itching (pruritus)","Stop disease progression","Improve sleep and comfort"];
  stGoals.forEach((g, i) => {
    s.addShape(prs.ShapeType.ellipse, { x:0.42, y:1.72+i*0.52, w:0.25, h:0.25, fill:{ color: TEAL } });
    s.addText(`${i+1}`, { x:0.42, y:1.72+i*0.52, w:0.25, h:0.25, fontSize:8, bold:true, color:WHITE, align:"center", valign:"middle", margin:0 });
    s.addText(g, { x:0.76, y:1.68+i*0.52, w:4.0, h:0.4, fontSize:11, color:MID_GRAY, valign:"middle" });
  });

  // Long-term
  s.addShape(prs.ShapeType.rect, { x:5.1, y:1.18, w:4.65, h:3.35, fill:{ color: WHITE }, line:{ color: NAVY, width:2 } });
  s.addShape(prs.ShapeType.rect, { x:5.1, y:1.18, w:4.65, h:0.45, fill:{ color: NAVY } });
  s.addText("LONG-TERM GOALS", { x:5.25, y:1.18, w:3.2, h:0.45, fontSize:SUB-8, bold:true, color:WHITE, valign:"middle", margin:0 });
  s.addText("3–6 Months", { x:8.45, y:1.18, w:1.2, h:0.45, fontSize:SMALL, color:"AECBEA", align:"right", valign:"middle", margin:0 });
  const ltGoals = ["Achieve PASI-75 or PASI-90 response","Prevent future flare-ups","Improve quality of life","Maintain long-term disease control","Minimize treatment-related toxicity"];
  ltGoals.forEach((g, i) => {
    s.addShape(prs.ShapeType.ellipse, { x:5.27, y:1.72+i*0.52, w:0.25, h:0.25, fill:{ color: NAVY } });
    s.addText(`${i+1}`, { x:5.27, y:1.72+i*0.52, w:0.25, h:0.25, fontSize:8, bold:true, color:WHITE, align:"center", valign:"middle", margin:0 });
    s.addText(g, { x:5.62, y:1.68+i*0.52, w:4.0, h:0.4, fontSize:11, color:MID_GRAY, valign:"middle" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 13 – NON-PHARMACOLOGICAL MANAGEMENT
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "NON-PHARMACOLOGICAL MANAGEMENT", "Lifestyle & Supportive Interventions");
  footer(s, 13, "Non-Pharmacological Management");

  const items = [
    { title:"Regular Moisturization", col: TEAL, bg: LIGHT_TEAL,
      text:"Apply emollients (petroleum jelly, paraffin, ceramide creams) 3–4 times daily to reduce dryness, scaling, and itching." },
    { title:"Proper Skin Care", col: NAVY, bg: LIGHT_NAVY,
      text:"Lukewarm water for bathing; avoid hot showers and harsh soaps; pat skin dry and apply moisturizer immediately after." },
    { title:"Stress Management", col:"6A5ACD", bg:"F0EEF9",
      text:"Practice yoga, meditation, deep breathing, and ensure adequate sleep." },
    { title:"Avoid Skin Trauma", col: CORAL, bg: LIGHT_CORAL,
      text:"Avoid scratching, rubbing, and tight clothing to prevent the Koebner phenomenon." },
    { title:"Lifestyle Modification", col: GREEN, bg:"E8F5E9",
      text:"Stop smoking, limit alcohol consumption, maintain a healthy body weight." },
    { title:"Regular Exercise", col:"0277BD", bg:"E3F2FD",
      text:"Moderate physical activity to improve overall health and reduce stress levels." },
    { title:"Avoid Triggers", col: AMBER, bg:"FFF8E1",
      text:"Avoid stress, skin injury, infections, and medications that may worsen psoriasis." },
    { title:"Patient Education", col:"546E7A", bg:"ECEFF1",
      text:"Psoriasis is a chronic, non-contagious disease requiring long-term management and adherence." },
  ];

  items.forEach((item, i) => {
    const x = 0.25 + (i%2)*4.9;
    const y = 1.18 + Math.floor(i/2)*1.04;
    s.addShape(prs.ShapeType.rect, { x, y, w:4.6, h:0.96, fill:{ color:item.bg }, line:{ color:item.col, width:1 } });
    s.addShape(prs.ShapeType.rect, { x, y, w:0.08, h:0.96, fill:{ color:item.col } });
    s.addText(item.title, { x:x+0.16, y:y+0.04, w:4.3, h:0.3, fontSize:SMALL+1, bold:true, color:item.col, margin:0 });
    s.addText(item.text,  { x:x+0.16, y:y+0.36, w:4.3, h:0.56, fontSize:SMALL, color:MID_GRAY, valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 14 – PHARMACOLOGICAL TREATMENT TABLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "PHARMACOLOGICAL TREATMENT REGIMEN", "Drug Therapy Plan");
  footer(s, 14, "Pharmacological Treatment Regimen");

  const rxData = [
    ["Inj. Secukinumab",                 "300 mg","SC",     "Wks 0,1,2,3,4 → q4w",   "Long-term maintenance"],
    ["Tab. Cyclosporine",                "75 mg", "PO",     "Twice daily",             "4–8 wks → taper after biologic response"],
    ["Clobetasol Propionate 0.05% Oint.","–",     "Topical","Twice daily",             "2–4 weeks"],
    ["Clobetasol 0.05% Scalp Solution",  "–",     "Topical","Once daily",              "2–4 weeks"],
    ["Calcipotriol 0.005% Ointment",     "–",     "Topical","Twice daily",             "Long-term maintenance"],
    ["Tab. Cetirizine",                  "10 mg", "PO",     "Once daily (bedtime)",    "2–4 wks or until resolved"],
    ["Emollients / Moisturizers",        "–",     "Topical","3–4 times daily",         "Continuous / Long-term"],
  ];

  const cols  = ["DRUG","DOSE","ROA","FREQUENCY","DURATION"];
  const cw    = [2.7, 0.7, 0.6, 2.4, 3.1];
  const startX = 0.25;
  let cx = startX;

  s.addShape(prs.ShapeType.rect, { x:startX, y:1.18, w:9.5, h:0.42, fill:{ color: NAVY } });
  cols.forEach((c, ci) => {
    s.addText(c, { x:cx+0.06, y:1.18, w:cw[ci]-0.06, h:0.42, fontSize:SMALL, bold:true, color:WHITE, valign:"middle", margin:0 });
    cx += cw[ci];
  });

  const rowColors = [WHITE, LIGHT_GRAY];
  const leftColors = [TEAL, NAVY, "6A5ACD", "6A5ACD", "0277BD", AMBER, GREEN];
  rxData.forEach((row, ri) => {
    const ry = 1.6 + ri*0.54;
    s.addShape(prs.ShapeType.rect, { x:startX, y:ry, w:9.5, h:0.52, fill:{ color:rowColors[ri%2] }, line:{ color: LIGHT_GRAY, width:0.5 } });
    s.addShape(prs.ShapeType.rect, { x:startX, y:ry, w:0.05, h:0.52, fill:{ color:leftColors[ri] } });
    let rcx = startX;
    row.forEach((cell, ci) => {
      const bold = ci===0;
      const col  = ci===0 ? NAVY : MID_GRAY;
      s.addText(cell, { x:rcx+0.08, y:ry, w:cw[ci]-0.08, h:0.52, fontSize:SMALL, bold, color:col, valign:"middle", margin:0 });
      rcx += cw[ci];
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 15 – MONITORING FRAMEWORK
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "CLINICAL MONITORING FRAMEWORK", "Efficacy & Safety Parameters");
  footer(s, 15, "Clinical Monitoring Framework");

  // Efficacy
  card(s, 0.25, 1.18, 4.65, 2.72, "EFFICACY MONITORING", GREEN, "E8F5E9", GREEN);
  const eff = [
    "Reduction in redness (erythema)",
    "Reduction in scaling",
    "Reduction in itching (pruritus)",
    "Decrease in plaque thickness",
    "Improvement in BSA and PASI score",
    "Fewer flare-ups, better quality of life",
  ];
  eff.forEach((e, i) => {
    s.addText("✓  " + e, { x:0.4, y:1.62+i*0.36, w:4.35, h:0.33, fontSize:SMALL+0.5, color:MID_GRAY, margin:0 });
  });

  // Safety columns
  const safetyItems = [
    { title:"Cyclosporine", col: CORAL, bg: LIGHT_CORAL,
      items:["Blood pressure","Serum creatinine (SCr)","BUN & electrolytes (K⁺)","Uric acid"] },
    { title:"Secukinumab (Biologic)", col: NAVY, bg: LIGHT_NAVY,
      items:["Signs of infection","TB screening (pre-treatment)","CBC, LFT, RFT periodically"] },
    { title:"Topical Corticosteroids", col:"6A5ACD", bg:"F0EEF9",
      items:["Skin atrophy","Striae (stretch marks)","Local skin irritation"] },
  ];

  safetyItems.forEach((item, i) => {
    const y = 1.18 + i*1.0;
    s.addShape(prs.ShapeType.rect, { x:5.1, y, w:4.65, h:0.92, fill:{ color:item.bg }, line:{ color:item.col, width:1 } });
    s.addShape(prs.ShapeType.rect, { x:5.1, y, w:4.65, h:0.35, fill:{ color:item.col } });
    s.addText(item.title, { x:5.22, y, w:4.4, h:0.35, fontSize:SMALL+0.5, bold:true, color:WHITE, valign:"middle", margin:0 });
    item.items.forEach((t, ti) => {
      s.addText("⚠  " + t, { x:5.22, y:y+0.38+ti*0.19, w:4.4, h:0.18, fontSize:SMALL, color:MID_GRAY, margin:0 });
    });
  });

  // Follow-up
  s.addShape(prs.ShapeType.rect, { x:5.1, y:4.18, w:4.65, h:0.72, fill:{ color: LIGHT_TEAL }, line:{ color: TEAL, width:1.5 } });
  s.addText("FOLLOW-UP SCHEDULE", { x:5.25, y:4.22, w:4.3, h:0.28, fontSize:SMALL, bold:true, color:TEAL, charSpacing:2, margin:0 });
  s.addText("Review every 4–8 weeks to assess treatment response and adverse effects.", {
    x:5.25, y:4.52, w:4.35, h:0.32, fontSize:SMALL+0.5, color:MID_GRAY
  });

  // PASI target banner
  s.addShape(prs.ShapeType.rect, { x:0.25, y:5.0, w:9.5, h:0.4, fill:{ color: NAVY } });
  s.addText("TARGET:  PASI-75 by Week 16   |   PASI-90 by Month 6   |   Sustained PASI-90 for long-term maintenance", {
    x:0.4, y:5.0, w:9.1, h:0.4, fontSize:10, bold:true, color:WHITE, align:"center", valign:"middle"
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 16 – PATIENT COUNSELLING PART 1
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "PATIENT COUNSELLING", "Part 1 – Disease Education & Medication");
  footer(s, 16, "Patient Counselling – Part 1");

  // Disease Education
  s.addShape(prs.ShapeType.rect, { x:0.25, y:1.18, w:9.5, h:0.95, fill:{ color: LIGHT_TEAL }, line:{ color: TEAL, width:1.5 } });
  s.addText("DISEASE EDUCATION", { x:0.4, y:1.22, w:9.1, h:0.28, fontSize:SMALL, bold:true, color:TEAL, charSpacing:2, margin:0 });
  const edu = [
    "Psoriasis is a long-term autoimmune skin disease — it is NOT contagious.",
    "Treatment controls symptoms and prevents flare-ups; it does not permanently cure the disease.",
  ];
  edu.forEach((e, i) => {
    s.addText("•  " + e, { x:0.4, y:1.52+i*0.3, w:9.1, h:0.28, fontSize:SMALL+0.5, color:MID_GRAY });
  });

  // Two medication cards
  const meds = [
    { name:"Cyclosporine", col: CORAL, bg: LIGHT_CORAL,
      points:["Take regularly as prescribed","Avoid grapefruit juice (↑ drug levels)","Inform doctor of reduced urine output or swelling","Monitor blood pressure regularly at home"] },
    { name:"Secukinumab (Biologic)", col: NAVY, bg: LIGHT_NAVY,
      points:["Store injection in refrigerator (2–8°C)","Rotate injection site each time","Report fever, cough, or any signs of infection","Do not miss doses — follow the schedule"] },
  ];
  meds.forEach((m, i) => {
    const x = 0.25 + i*4.9;
    s.addShape(prs.ShapeType.rect, { x, y:2.28, w:4.65, h:2.85, fill:{ color: m.bg }, line:{ color: m.col, width:1.5 } });
    s.addShape(prs.ShapeType.rect, { x, y:2.28, w:4.65, h:0.42, fill:{ color: m.col } });
    s.addText(m.name, { x:x+0.12, y:2.28, w:4.4, h:0.42, fontSize:11, bold:true, color:WHITE, valign:"middle", margin:0 });
    m.points.forEach((p, pi) => {
      s.addText("→  " + p, { x:x+0.15, y:2.74+pi*0.56, w:4.35, h:0.52, fontSize:SMALL+0.5, color:MID_GRAY, valign:"middle" });
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 17 – PATIENT COUNSELLING PART 2 + THANK YOU
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bg(s);
  titleBar(s, "PATIENT COUNSELLING", "Part 2 – Topical Steroids & Lifestyle");
  footer(s, 17, "Patient Counselling – Part 2");

  // Topical steroids card
  s.addShape(prs.ShapeType.rect, { x:0.25, y:1.18, w:4.65, h:2.0, fill:{ color:"F0EEF9" }, line:{ color:"6A5ACD", width:1.5 } });
  s.addShape(prs.ShapeType.rect, { x:0.25, y:1.18, w:4.65, h:0.42, fill:{ color:"6A5ACD" } });
  s.addText("TOPICAL STEROIDS", { x:0.4, y:1.18, w:4.4, h:0.42, fontSize:11, bold:true, color:WHITE, valign:"middle", margin:0 });
  const topPoints = [
    "Apply only a thin layer to affected areas",
    "Do not use longer than prescribed",
    "Wash hands after applying the medication",
    "Do not apply to face unless specifically directed",
  ];
  topPoints.forEach((p, i) => {
    s.addText("→  " + p, { x:0.4, y:1.65+i*0.37, w:4.4, h:0.34, fontSize:SMALL+0.5, color:MID_GRAY });
  });

  // Lifestyle card
  s.addShape(prs.ShapeType.rect, { x:0.25, y:3.32, w:4.65, h:1.82, fill:{ color:"E8F5E9" }, line:{ color: GREEN, width:1.5 } });
  s.addShape(prs.ShapeType.rect, { x:0.25, y:3.32, w:4.65, h:0.42, fill:{ color: GREEN } });
  s.addText("LIFESTYLE COUNSELLING", { x:0.4, y:3.32, w:4.4, h:0.42, fontSize:11, bold:true, color:WHITE, valign:"middle", margin:0 });
  const lifestyle = [
    "Use moisturizers daily to keep the skin hydrated",
    "Avoid scratching the lesions",
    "Manage stress through relaxation techniques and adequate sleep",
    "Stop smoking and limit alcohol intake",
  ];
  lifestyle.forEach((p, i) => {
    s.addText("✓  " + p, { x:0.4, y:3.78+i*0.34, w:4.4, h:0.31, fontSize:SMALL+0.5, color:MID_GRAY });
  });

  // Thank you / summary panel
  s.addShape(prs.ShapeType.rect, { x:5.1, y:1.18, w:4.65, h:3.96, fill:{ color: NAVY }, line:{ color: TEAL, width:2 } });
  s.addShape(prs.ShapeType.ellipse, { x:5.5, y:0.9, w:3, h:3, fill:{ color: TEAL, transparency:88 } });
  s.addText("Thank You", { x:5.2, y:1.55, w:4.4, h:0.9, fontSize:34, bold:true, color:WHITE, align:"center" });
  s.addShape(prs.ShapeType.line, { x:5.6, y:2.52, w:3.5, h:0, line:{ color: TEAL, width:2 } });
  s.addText("Questions & Discussion", { x:5.2, y:2.6, w:4.4, h:0.42, fontSize:14, color:"AECBEA", align:"center", italic:true });
  s.addShape(prs.ShapeType.rect, { x:5.3, y:3.15, w:4.3, h:1.5, fill:{ color:"0D2237" }, line:{ color: TEAL, width:1 } });
  s.addText("CASE SUMMARY", { x:5.45, y:3.2, w:3.9, h:0.28, fontSize:SMALL, bold:true, color: TEAL, charSpacing:3, align:"center" });
  s.addText(
    "50M  ·  Severe Plaque Psoriasis\n27-yr refractory disease\nRec: Secukinumab + Cyclosporine bridge\n+ Topicals + Cetirizine + Emollients",
    { x:5.45, y:3.5, w:3.9, h:1.1, fontSize:SMALL+0.5, color:WHITE, align:"center" }
  );
}

// ─── WRITE FILE ───────────────────────────────────────────────────
prs.writeFile({ fileName: "/home/daytona/workspace/plaque-psoriasis-ppt/Plaque_Psoriasis_Case_Light.pptx" })
  .then(() => console.log("SUCCESS"))
  .catch(e => { console.error("ERROR:", e); process.exit(1); });

Running Command

cd /home/daytona/workspace/plaque-psoriasis-ppt && node build_light.js 2>&1

Running Command

ls -lh /home/daytona/workspace/plaque-psoriasis-ppt/Plaque_Psoriasis_Case_Light.pptx

Your presentation is ready! Download it here:

Plaque Psoriasis Case Light

Presentation · PPTX

What's new in this version:

Feature	Details
Background	Light (`#F5F7FA` near-white) with white cards — clean, printable look
Headline font	28 pt bold on all slide header bars
Sub-headline font	24 pt italic on all secondary title lines
Colour theme	Navy (`#1A3557`) + Teal (`#0D7377`) + Coral accent — professional medical palette on white
Total slides	17 slides matching the uploaded content exactly

Slide breakdown:

Title slide (two-tone white/navy split layout)
Patient Profile — info table + chief complaint + clinical note
HPI Part 1 — 4 event cards (diagnosis → PUVA loss)
HPI Part 2 — 3 horizontal event rows (MTX → cyclosporine → current flare)
Medical / Family / Social History — structured cards with risk amplifiers
Objective Data — vital metric boxes + skin exam grid
Lab Data: CBC & Renal — color-coded table with Hct flag warning
Lab Data: LFT — with clinical interpretation note
Lab Data: Electrolytes & Chemistry — with cyclosporine safety note
Assessment: Diagnosis & Severity — PASI/BSA metrics + evidence
Assessment: Drug Therapy Problems — 6 DTP cards (color-coded by severity)
Planning: Goals — short-term vs long-term side by side
Non-Pharmacological Management — 8 intervention cards
Pharmacological Treatment — full drug table with 7 agents
Clinical Monitoring Framework — efficacy + safety + PASI targets
Patient Counselling Part 1 — disease education + cyclosporine + secukinumab
Patient Counselling Part 2 — topical steroids + lifestyle + Thank You summary

Use three shade of same colour and prepare ppt

Rebuilding the PPT using three shades of a single colour — I'll go with a professional teal/blue-green monochromatic palette: dark, mid, and light.

Writing File

~/plaque-psoriasis-ppt/build_mono.js

const pptxgen = require("pptxgenjs");

const prs = new pptxgen();
prs.layout  = "LAYOUT_16x9";
prs.title   = "Plaque Psoriasis Case Study";
prs.author  = "Ganavi C";

// ─── THREE SHADES OF TEAL ──────────────────────────────────────────
const DARK   = "0B4F6C";   // shade 1 – deep teal  (headers, accents)
const MID    = "1A8A9B";   // shade 2 – mid teal   (cards, bands)
const LIGHT  = "D6F0F4";   // shade 3 – pale teal  (backgrounds, alt rows)

const WHITE  = "FFFFFF";
const TEXT_D = "0B3A4F";   // very dark teal for body text
const TEXT_M = "1D5C6E";   // mid-dark teal for secondary text

// Font sizes as required
const HEAD   = 28;         // headline
const SUB    = 24;         // sub-headline
const BODY   = 11;
const SMALL  = 9.5;

// ─── HELPERS ──────────────────────────────────────────────────────

function bgLight(slide) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:0, w:10, h:5.625, fill:{ color: WHITE } });
}

function titleBar(slide, headline, sub) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:0,    w:10, h:1.05, fill:{ color: DARK } });
  slide.addShape(prs.ShapeType.rect, { x:0, y:1.05, w:10, h:0.06, fill:{ color: MID  } });
  slide.addText(headline, {
    x:0.35, y:0.04, w:9.3, h:0.62,
    fontSize:HEAD, bold:true, color:WHITE, valign:"bottom", margin:0
  });
  if (sub) {
    slide.addText(sub, {
      x:0.35, y:0.66, w:9.3, h:0.36,
      fontSize:SUB, color:LIGHT, valign:"top", italic:true, margin:0
    });
  }
}

function footer(slide, num, label) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:5.43, w:10, h:0.195, fill:{ color: DARK } });
  slide.addText(`Slide ${num}  ·  ${label}`, {
    x:0.2, y:5.43, w:5, h:0.195, fontSize:7.5, color:LIGHT, valign:"middle", margin:0
  });
  slide.addText("Plaque Psoriasis Case  ·  Ganavi C  ·  V Pharm D  ·  21Q0275", {
    x:5, y:5.43, w:4.8, h:0.195, fontSize:7.5, color:LIGHT, align:"right", valign:"middle", margin:0
  });
}

// Card with optional title strip
function card(slide, x, y, w, h, title) {
  slide.addShape(prs.ShapeType.rect, {
    x, y, w, h, fill:{ color: LIGHT }, line:{ color: MID, width:1 }
  });
  if (title) {
    slide.addShape(prs.ShapeType.rect, { x, y, w, h:0.38, fill:{ color: MID } });
    slide.addText(title, {
      x:x+0.12, y, w:w-0.2, h:0.38,
      fontSize:SMALL+1, bold:true, color:WHITE, valign:"middle", charSpacing:1, margin:0
    });
  }
}

// Lab table (3-col)
function labTable(slide, x, y, w, title, rows) {
  const HDR_H = 0.36, COL_H = 0.38;
  const cw = [w*0.44, w*0.28, w*0.28];

  // title row
  slide.addShape(prs.ShapeType.rect, { x, y, w, h:HDR_H, fill:{ color: DARK } });
  slide.addText(title, { x:x+0.1, y, w:w-0.15, h:HDR_H, fontSize:SMALL+1, bold:true, color:WHITE, valign:"middle", margin:0 });

  // sub-header
  const sy = y+HDR_H;
  slide.addShape(prs.ShapeType.rect, { x, y:sy, w, h:HDR_H, fill:{ color: MID } });
  let cx = x;
  ["Parameter","Result","Normal Range"].forEach((h,ci)=>{
    slide.addText(h,{ x:cx+0.06, y:sy, w:cw[ci]-0.06, h:HDR_H, fontSize:SMALL, bold:true, color:WHITE, valign:"middle", margin:0 });
    cx += cw[ci];
  });

  // data rows
  rows.forEach((row,ri)=>{
    const ry = sy+HDR_H+ri*COL_H;
    const fill = ri%2===0 ? WHITE : LIGHT;
    slide.addShape(prs.ShapeType.rect,{ x, y:ry, w, h:COL_H, fill:{ color:fill }, line:{ color:LIGHT, width:0.5 } });
    let rcx = x;
    row.slice(0,3).forEach((cell,ci)=>{
      const isLow  = row[3]==="L" || (typeof cell==="string" && cell.toLowerCase().includes("low"));
      const tc = ci===0 ? TEXT_D : (ci===1 && isLow) ? MID : TEXT_M;
      slide.addText(cell,{ x:rcx+0.06, y:ry, w:cw[ci]-0.06, h:COL_H, fontSize:SMALL, bold:ci===0, color:tc, valign:"middle", margin:0 });
      rcx += cw[ci];
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 1 – TITLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  // Full background – white
  s.addShape(prs.ShapeType.rect,{ x:0,y:0,w:10,h:5.625, fill:{ color:WHITE } });
  // Left panel – dark teal
  s.addShape(prs.ShapeType.rect,{ x:0,y:0,w:3.8,h:5.625, fill:{ color:DARK } });
  // Divider strip – mid teal
  s.addShape(prs.ShapeType.rect,{ x:3.8,y:0,w:0.07,h:5.625, fill:{ color:MID } });
  // Decorative circles
  s.addShape(prs.ShapeType.ellipse,{ x:-1.0,y:-1.0,w:4,h:4, fill:{ color:MID, transparency:80 } });
  s.addShape(prs.ShapeType.ellipse,{ x:0.5,y:3.9,w:2.6,h:2.6, fill:{ color:LIGHT, transparency:70 } });

  // Left text
  s.addText("CASE\nSTUDY",{ x:0.15,y:0.55,w:3.5,h:1.45, fontSize:36,bold:true,color:WHITE,align:"center",charSpacing:7 });
  s.addShape(prs.ShapeType.line,{ x:0.55,y:2.1,w:2.6,h:0, line:{ color:MID,width:2 } });
  s.addText("Dermatology &\nClinical Pharmacy",{ x:0.15,y:2.22,w:3.5,h:0.7, fontSize:13,color:LIGHT,align:"center",italic:true });

  // Presenter box
  s.addShape(prs.ShapeType.rect,{ x:0.28,y:3.3,w:3.2,h:1.65, fill:{ color:"062D3F" }, line:{ color:MID,width:1 } });
  s.addText("PRESENTED BY",{ x:0.38,y:3.37,w:3.0,h:0.28, fontSize:8,bold:true,color:MID,align:"center",charSpacing:3,margin:0 });
  s.addText([
    { text:"Ganavi C\n", options:{ bold:true,fontSize:15 } },
    { text:"V Pharm D\n", options:{ fontSize:12 } },
    { text:"Reg No: 21Q0275", options:{ fontSize:10,color:LIGHT } }
  ],{ x:0.38,y:3.68,w:3.0,h:1.05,color:WHITE,align:"center" });

  // Right main title
  s.addText("Plaque Psoriasis",{ x:4.1,y:0.6,w:5.65,h:1.05, fontSize:HEAD+10,bold:true,color:DARK });
  s.addText("Clinical Case Study",{ x:4.1,y:1.65,w:5.65,h:0.52, fontSize:SUB,color:MID,italic:true });
  s.addShape(prs.ShapeType.line,{ x:4.1,y:2.25,w:5.2,h:0, line:{ color:MID,width:2 } });

  // Tag chips – three teal shades
  const tags = [
    { t:"Severe",           fill:DARK },
    { t:"Chronic",          fill:MID  },
    { t:"Uncontrolled",     fill:DARK },
    { t:"Biologic Candidate", fill:MID },
  ];
  tags.forEach((tg,i)=>{
    s.addShape(prs.ShapeType.roundRect,{ x:4.1+i*1.42,y:2.38,w:1.34,h:0.33, fill:{ color:tg.fill }, line:{ color:MID,width:0 }, rectRadius:0.05 });
    s.addText(tg.t,{ x:4.1+i*1.42,y:2.38,w:1.34,h:0.33, fontSize:8,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
  });

  s.addText("A 50-year-old male with a 27-year history of plaque psoriasis\npresenting with severe, uncontrolled disease despite multiple lines of therapy.",{
    x:4.1,y:2.85,w:5.65,h:0.8, fontSize:10.5,color:TEXT_M,italic:true
  });

  // Bottom footer strip
  s.addShape(prs.ShapeType.rect,{ x:0,y:5.43,w:10,h:0.195, fill:{ color:LIGHT } });
  s.addText("V Pharm D  ·  Clinical Pharmacy Case Presentation  ·  2024",{
    x:0,y:5.43,w:10,h:0.195, fontSize:8.5,color:DARK,align:"center",valign:"middle"
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 2 – PATIENT PROFILE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"SUBJECTIVE DATA","Patient Profile");
  footer(s,2,"Subjective Data – Patient Profile");

  // Patient table card
  card(s, 0.25,1.18,4.55,3.35,"PATIENT INFORMATION");
  const patRows=[
    ["Age","50 years"],["Gender","Male"],
    ["Occupation","Elementary School Teacher"],
    ["Weight","75 kg"],["Height","5'9\""],["Allergies","NKA"]
  ];
  patRows.forEach(([k,v],i)=>{
    const ry=1.6+i*0.47;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:4.55,h:0.44, fill:{ color:i%2===0?WHITE:LIGHT } });
    s.addText(k,{ x:0.38,y:ry,w:1.85,h:0.44, fontSize:SMALL+0.5,bold:true,color:DARK,valign:"middle",margin:0 });
    s.addText(v,{ x:2.25,y:ry,w:2.42,h:0.44, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle",margin:0 });
  });

  // Chief complaint
  s.addShape(prs.ShapeType.rect,{ x:5.05,y:1.18,w:4.7,h:1.12, fill:{ color:LIGHT }, line:{ color:DARK,width:2 } });
  s.addShape(prs.ShapeType.rect,{ x:5.05,y:1.18,w:4.7,h:0.36, fill:{ color:DARK } });
  s.addText("CHIEF COMPLAINT",{ x:5.18,y:1.18,w:4.4,h:0.36, fontSize:SMALL,bold:true,color:WHITE,valign:"middle",charSpacing:2,margin:0 });
  s.addText('"Nothing is helping my psoriasis."',{
    x:5.18,y:1.57,w:4.4,h:0.68, fontSize:13.5,color:DARK,italic:true,valign:"middle"
  });

  // Clinical note
  card(s, 5.05,2.44,4.7,2.09,"CLINICAL NOTE");
  s.addText(
    "Subjective data emphasizes significant mental burden and clinical therapeutic non-response to conventional treatment routes.\n\nPatient presents with clear frustration after years of escalating treatment without adequate disease control.",
    { x:5.18,y:2.87,w:4.45,h:1.6, fontSize:SMALL+0.5,color:TEXT_M }
  );
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 3 – HPI PART 1
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"HISTORY OF PRESENT ILLNESS","27-Year Treatment Chronology – Part 1");
  footer(s,3,"HPI – Treatment Timeline Part 1");

  s.addText("Chronological course of medical interventions since early diagnosis:",{
    x:0.3,y:1.18,w:9.4,h:0.28, fontSize:SMALL+1,color:TEXT_M,italic:true
  });

  // 4 event cards — alternating dark/mid/light tones
  const events=[
    { label:"Initial Diagnosis",    age:"Age 23",
      text:"Plaque psoriasis diagnosed. Initially achieved good control with medium-potency topical corticosteroids.",
      hdr:DARK, bg:LIGHT },
    { label:"Combination Course",   age:"Mid-course",
      text:"Calcipotriol therapy added when topical corticosteroids alone became insufficient for disease control.",
      hdr:MID, bg:WHITE },
    { label:"Phototherapy Run",     age:"Disease progression",
      text:"PUVA (Psoralen + UVA) phototherapy initiated — provided temporary improvement before losing efficacy.",
      hdr:DARK, bg:LIGHT },
    { label:"Efficacy Loss",        age:"Later",
      text:"PUVA gradually lost effectiveness, resulting in inadequate disease control and recurrent lesions.",
      hdr:MID, bg:WHITE },
  ];
  events.forEach((e,i)=>{
    const x=0.25+(i%2)*4.9, y=i<2?1.58:3.2;
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:1.48, fill:{ color:e.bg }, line:{ color:e.hdr,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:0.42, fill:{ color:e.hdr } });
    s.addText(e.label,{ x:x+0.12,y,w:3.1,h:0.42, fontSize:SMALL+1.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(e.age,{ x:x+3.2,y,w:1.28,h:0.42, fontSize:SMALL,color:LIGHT,align:"right",valign:"middle",margin:0 });
    s.addText(e.text,{ x:x+0.12,y:y+0.48,w:4.35,h:0.96, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 4 – HPI PART 2
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"HISTORY OF PRESENT ILLNESS","27-Year Treatment Chronology – Part 2");
  footer(s,4,"HPI – Treatment Timeline Part 2");

  const events=[
    { label:"Systemic Methotrexate Escalation", hdr:DARK, bg:LIGHT,
      left:"Frequent flare-ups despite increasing methotrexate doses — SCAT used for acute exacerbations.",
      right:"MTX escalated to 25 mg/week. Cumulative lifetime dose reached 2.2 g." },
    { label:"Switch: Cyclosporine + Acitretin",  hdr:MID, bg:WHITE,
      left:"Treatment changed to cyclosporine 75 mg twice daily + acitretin 25 mg daily.",
      right:"Acitretin discontinued due to severe xerosis (dry skin side effect)." },
    { label:"Current Presentation – 3rd Severe Flare", hdr:DARK, bg:LIGHT,
      left:"Cyclosporine alone provided good control for 1 year after acitretin stopped.",
      right:"Two severe flare-ups in past 6 months. Current = 3rd and most severe flare." },
  ];
  events.forEach((e,i)=>{
    const y=1.22+i*1.35;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y,w:9.5,h:1.22, fill:{ color:e.bg }, line:{ color:e.hdr,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x:0.25,y,w:9.5,h:0.4, fill:{ color:e.hdr } });
    s.addText(`${i+1}.  ${e.label}`,{ x:0.4,y,w:9.1,h:0.4, fontSize:11,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText("•  "+e.left,{ x:0.4,y:y+0.44,w:4.55,h:0.73, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
    s.addText("•  "+e.right,{ x:5.1,y:y+0.44,w:4.5,h:0.73, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 5 – MEDICAL / FAMILY / SOCIAL HISTORY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"MEDICAL, FAMILY & SOCIAL HISTORY","Background & Risk Factors");
  footer(s,5,"Medical / Family / Social History");

  // Medical & Family
  card(s,0.25,1.18,4.55,2.4,"MEDICAL & FAMILY HISTORY");
  const mf=[["PMH","Major depressive episode — 16 years ago"],["Brother","Has psoriasis"],["Father","Hypertension + Type 2 Diabetes"]];
  mf.forEach(([k,v],i)=>{
    const ry=1.62+i*0.6;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:4.55,h:0.56, fill:{ color:i%2===0?WHITE:LIGHT } });
    s.addText(k,{ x:0.38,y:ry,w:1.1,h:0.56, fontSize:SMALL,bold:true,color:DARK,valign:"middle",margin:0 });
    s.addText(v,{ x:1.5,y:ry,w:3.15,h:0.56, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle" });
  });

  // Social
  card(s,5.05,1.18,4.7,2.4,"SOCIAL PROFILE & TRIGGERS");
  const soc=[["Smoking","Former heavy smoker"],["Alcohol","One glass of wine daily"],["Stress","Increased occupational stress"],["Family","Married with children"]];
  soc.forEach(([k,v],i)=>{
    const ry=1.62+i*0.48;
    s.addShape(prs.ShapeType.rect,{ x:5.05,y:ry,w:4.7,h:0.44, fill:{ color:i%2===0?WHITE:LIGHT } });
    s.addText(k,{ x:5.18,y:ry,w:1.2,h:0.44, fontSize:SMALL,bold:true,color:DARK,valign:"middle",margin:0 });
    s.addText(v,{ x:6.4,y:ry,w:3.2,h:0.44, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle" });
  });

  // Allergies
  card(s,0.25,3.72,4.55,0.95,"ALLERGIES & TOLERABILITY");
  s.addText("NKA  —  No Known Allergies",{ x:0.4,y:4.14,w:4.3,h:0.28, fontSize:SMALL+1,bold:true,color:DARK });
  s.addText("Drug intolerance: Acitretin — severe xerosis confirmed",{ x:0.4,y:4.42,w:4.3,h:0.22, fontSize:SMALL,color:TEXT_M });

  // Risk note
  card(s,5.05,3.72,4.7,0.95,"RISK AMPLIFIERS");
  s.addText("Smoking, alcohol, and occupational stress are established psoriasis flare triggers and may contribute to treatment resistance.",{
    x:5.18,y:4.14,w:4.45,h:0.55, fontSize:SMALL+0.5,color:TEXT_M
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 6 – OBJECTIVE DATA
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"OBJECTIVE DATA","Vital Signs & Physical Examination");
  footer(s,6,"Objective Data – Vitals & Skin Exam");

  // Vital boxes – dark / mid / dark / mid shading
  const vitals=[
    { label:"BLOOD PRESSURE", val:"129/83", unit:"mmHg",       col:DARK },
    { label:"PULSE RATE",     val:"88",     unit:"bpm",        col:MID  },
    { label:"TEMPERATURE",   val:"37°C",   unit:"Normal",     col:DARK },
    { label:"APPEARANCE",    val:"Alert",  unit:"Mild anxiety",col:MID  },
  ];
  vitals.forEach((v,i)=>{
    const x=0.25+i*2.42;
    s.addShape(prs.ShapeType.rect,{ x,y:1.18,w:2.3,h:1.25, fill:{ color:LIGHT }, line:{ color:v.col,width:2 } });
    s.addShape(prs.ShapeType.rect,{ x,y:1.18,w:2.3,h:0.36, fill:{ color:v.col } });
    s.addText(v.label,{ x:x+0.07,y:1.18,w:2.16,h:0.36, fontSize:7.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(v.val,{ x:x+0.07,y:1.56,w:2.16,h:0.52, fontSize:22,bold:true,color:v.col,align:"center" });
    s.addText(v.unit,{ x:x+0.07,y:2.09,w:2.16,h:0.3, fontSize:SMALL,color:TEXT_M,align:"center" });
  });

  // Skin exam card
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:2.57,w:9.5,h:2.62, fill:{ color:LIGHT }, line:{ color:DARK,width:1.5 } });
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:2.57,w:9.5,h:0.42, fill:{ color:DARK } });
  s.addText("SKIN EXAMINATION — Severe Plaque Psoriasis",{
    x:0.4,y:2.57,w:9.15,h:0.42, fontSize:11,bold:true,color:WHITE,valign:"middle",charSpacing:1,margin:0
  });

  // Location chips
  const locs=["Abdomen","Arms","Legs","Back","Scalp","Palms","Soles","Elbows","Knees"];
  s.addText("Locations:",{ x:0.4,y:3.06,w:1.3,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  locs.forEach((loc,i)=>{
    const lx=1.65+i*0.86;
    s.addShape(prs.ShapeType.roundRect,{ x:lx,y:3.06,w:0.8,h:0.28, fill:{ color:MID }, line:{ color:DARK,width:0 }, rectRadius:0.04 });
    s.addText(loc,{ x:lx,y:3.06,w:0.8,h:0.28, fontSize:7.5,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
  });
  s.addText("Visual Profile:",{ x:0.4,y:3.44,w:1.6,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  s.addText("Thick plaques  ·  Erythematous lesions  ·  Well-demarcated borders  ·  Confluent lesions",{
    x:1.95,y:3.44,w:7.55,h:0.28, fontSize:SMALL+0.5,color:TEXT_M,margin:0
  });
  s.addText("Secondary Signs:",{ x:0.4,y:3.78,w:1.8,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  s.addText("Silvery-white scales  ·  Excoriations due to scratching",{
    x:2.2,y:3.78,w:7.3,h:0.28, fontSize:SMALL+0.5,color:TEXT_M,margin:0
  });
  s.addText("General Status:",{ x:0.4,y:4.12,w:1.8,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  s.addText("Alert, oriented  ·  Mild anxiety noted",{
    x:2.2,y:4.12,w:7.3,h:0.28, fontSize:SMALL+0.5,color:TEXT_M,margin:0
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 7 – LAB: CBC & RENAL
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"LABORATORY DATA","Complete Blood Count & Renal Panel");
  footer(s,7,"Lab Data – CBC & Renal");

  labTable(s,0.25,1.18,9.5,"COMPLETE BLOOD COUNT (CBC)",[
    ["Hemoglobin (Hb)",  "13.5 g/dL",       "13.5–17.5 g/dL","N"],
    ["Hematocrit (Hct)", "35% (Mildly Low)", "40–52%",        "L"],
    ["WBC",              "6.0 ×10³/mm³",     "4–11 ×10³/mm³", "N"],
    ["Platelets",        "255 ×10³/mm³",     "150–400 ×10³/mm³","N"],
  ]);
  labTable(s,0.25,3.72,9.5,"RENAL FUNCTION TEST (RFT)",[
    ["Blood Urea Nitrogen (BUN)","14 mg/dL","7–20 mg/dL",   "N"],
    ["Creatinine (SCr)",         "1.0 mg/dL","0.6–1.3 mg/dL","N"],
  ]);
  // Flag note
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:5.18,w:9.5,h:0.24, fill:{ color:LIGHT }, line:{ color:MID,width:0.75 } });
  s.addText("⚠  Hematocrit (35%) is mildly below normal (40–52%) — monitor for anemia.",{
    x:0.4,y:5.18,w:9.2,h:0.24, fontSize:8.5,color:DARK,valign:"middle",margin:0
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 8 – LAB: LFT
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"LABORATORY DATA","Liver Function Profile");
  footer(s,8,"Lab Data – Liver Function");

  labTable(s,0.25,1.18,9.5,"LIVER FUNCTION TEST (LFT)",[
    ["AST (SGOT)",               "22 IU/L",  "10–40 IU/L",   "N"],
    ["ALT (SGPT)",               "38 IU/L",  "7–56 IU/L",    "N"],
    ["Alkaline Phosphatase (ALP)","98 IU/L", "44–147 IU/L",  "N"],
    ["Total Bilirubin",          "1.0 mg/dL","0.1–1.2 mg/dL","N"],
    ["Albumin",                  "3.7 g/dL", "3.5–5.0 g/dL", "N"],
  ]);

  card(s,0.25,4.1,9.5,1.02,"CLINICAL INTERPRETATION");
  s.addText(
    "All liver function parameters are within normal limits — clinically significant given the patient's history of methotrexate use (cumulative dose 2.2 g), which carries hepatotoxicity risk. Normal LFTs support safe transition to biologic therapy (Secukinumab).",
    { x:0.4,y:4.52,w:9.2,h:0.55, fontSize:SMALL+0.5,color:TEXT_M }
  );
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 9 – LAB: ELECTROLYTES & CHEMISTRY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"LABORATORY DATA","Electrolytes & Chemistry Panel");
  footer(s,9,"Lab Data – Electrolytes & Chemistry");

  labTable(s,0.25,1.18,9.5,"ELECTROLYTES & CHEMISTRY",[
    ["Sodium (Na⁺)",            "139 mEq/L","135–145 mEq/L","N"],
    ["Potassium (K⁺)",          "4.0 mEq/L","3.5–5.0 mEq/L","N"],
    ["Chloride (Cl⁻)",          "102 mEq/L","98–106 mEq/L", "N"],
    ["Bicarbonate (HCO₃⁻/CO₂)","25 mEq/L", "22–28 mEq/L",  "N"],
    ["Uric Acid",               "4 mg/dL",  "3.5–7.2 mg/dL","N"],
    ["Total Cholesterol",       "180 mg/dL","<200 mg/dL",   "N"],
    ["Blood Glucose",           "98 mg/dL", "70–110 mg/dL", "N"],
  ]);

  card(s,0.25,4.92,9.5,0.65,"CYCLOSPORINE SAFETY NOTE");
  s.addText(
    "Potassium and renal parameters are within normal limits — important for cyclosporine safety (hyperkalemia and nephrotoxicity monitoring).",
    { x:0.4,y:5.18,w:9.2,h:0.35, fontSize:SMALL+0.5,color:TEXT_M }
  );
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 10 – ASSESSMENT: DIAGNOSIS & SEVERITY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"ASSESSMENT","Diagnosis & Severity Profile");
  footer(s,10,"Assessment – Diagnosis & Severity");

  // Diagnosis strip
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.62, fill:{ color:DARK } });
  s.addText("PRIMARY DIAGNOSIS",{ x:0.42,y:1.2,w:2.8,h:0.28, fontSize:SMALL,bold:true,color:LIGHT,charSpacing:2,margin:0 });
  s.addText("Severe Chronic Plaque Psoriasis (Uncontrolled)",{
    x:0.42,y:1.46,w:9.0,h:0.3, fontSize:14,bold:true,color:WHITE,margin:0
  });

  // Metric cards
  const metrics=[
    { label:"BSA Involvement", val:">20%",   sub:"Severe threshold: >10%", shade:DARK },
    { label:"Estimated PASI",  val:">20",    sub:"Severe disease index",    shade:MID  },
    { label:"Disease Duration",val:"27 yrs", sub:"Chronic, refractory",     shade:DARK },
  ];
  metrics.forEach((m,i)=>{
    const x=0.25+i*3.25;
    s.addShape(prs.ShapeType.rect,{ x,y:1.95,w:3.1,h:1.25, fill:{ color:LIGHT }, line:{ color:m.shade,width:2 } });
    s.addText(m.label,{ x:x+0.1,y:1.98,w:2.9,h:0.3, fontSize:SMALL,bold:true,color:m.shade,margin:0 });
    s.addText(m.val,{ x:x+0.1,y:2.26,w:2.9,h:0.6, fontSize:28,bold:true,color:m.shade,align:"center" });
    s.addText(m.sub,{ x:x+0.1,y:2.86,w:2.9,h:0.28, fontSize:SMALL-0.5,color:TEXT_M,align:"center" });
  });

  // Evidence
  card(s,0.25,3.34,4.65,1.82,"CLINICAL EVIDENCE");
  ["Erythematous plaques with silvery scales",
   "Extensive body involvement",
   "Long-standing disease (27 years)",
   "Positive family history of psoriasis"
  ].forEach((e,i)=>{
    s.addText("✓  "+e,{ x:0.4,y:3.76+i*0.35,w:4.35,h:0.32, fontSize:SMALL+0.5,color:TEXT_M });
  });

  // Severity benchmarks
  card(s,5.1,3.34,4.65,1.82,"SEVERITY BENCHMARKS");
  ["BSA Involvement: >20%",
   "Areas: Scalp, Arms, Legs, Abdomen, Back, Palms, Soles",
   "Severity: Severe (>10% BSA)",
   "PASI Score: >20 (Severe disease index)"
  ].forEach((e,i)=>{
    s.addText("•  "+e,{ x:5.25,y:3.76+i*0.35,w:4.35,h:0.32, fontSize:SMALL+0.5,color:TEXT_M });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 11 – ASSESSMENT: DTPS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"ASSESSMENT","Drug Therapy Problems (DTPs)");
  footer(s,11,"Assessment – Drug Therapy Problems");

  const dtps=[
    { num:"DTP 1", title:"Refractory Uncontrolled Status",
      text:"Uncontrolled severe plaque psoriasis despite active cyclosporine therapy.", shade:DARK },
    { num:"DTP 2", title:"Subtherapeutic Efficacy",
      text:"Inadequate physiological response to current cyclosporine dosing regimen.", shade:MID  },
    { num:"DTP 3", title:"Historical Treatment Failures",
      text:"Previous failures: topical therapy, PUVA phototherapy, and methotrexate.", shade:DARK },
    { num:"DTP 4", title:"Adverse Event Intolerance",
      text:"Oral acitretin intolerance due to secondary severe xerosis (dry skin).", shade:MID  },
    { num:"DTP 5", title:"Severe Pruritus Burden",
      text:"Severe pruritus causing chronic scratching and skin excoriations.", shade:DARK },
    { num:"DTP 6", title:"Psychosocial Exacerbation",
      text:"Occupational stress contributing to disease flare-ups and worsening.", shade:MID  },
  ];
  dtps.forEach((d,i)=>{
    const x=0.25+(i%2)*4.9, y=1.18+Math.floor(i/2)*1.38;
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:1.26, fill:{ color:LIGHT }, line:{ color:d.shade,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:0.42, fill:{ color:d.shade } });
    s.addText(d.num,{ x:x+0.1,y,w:0.75,h:0.42, fontSize:SMALL,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(d.title,{ x:x+0.85,y,w:3.65,h:0.42, fontSize:SMALL+0.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(d.text,{ x:x+0.12,y:y+0.48,w:4.35,h:0.72, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 12 – PLANNING: GOALS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PLANNING","Goals of Therapy");
  footer(s,12,"Planning – Goals of Therapy");

  // Short-term
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:4.65,h:3.35, fill:{ color:LIGHT }, line:{ color:DARK,width:2 } });
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:4.65,h:0.45, fill:{ color:DARK } });
  s.addText("SHORT-TERM GOALS",{ x:0.4,y:1.18,w:3.2,h:0.45, fontSize:SUB-8,bold:true,color:WHITE,valign:"middle",margin:0 });
  s.addText("4–8 Weeks",{ x:3.6,y:1.18,w:1.2,h:0.45, fontSize:SMALL,color:LIGHT,align:"right",valign:"middle",margin:0 });
  ["Reduce erythema (redness)","Reduce scaling","Relieve itching (pruritus)",
   "Stop disease progression","Improve sleep and comfort"].forEach((g,i)=>{
    s.addShape(prs.ShapeType.ellipse,{ x:0.4,y:1.72+i*0.52,w:0.26,h:0.26, fill:{ color:DARK } });
    s.addText(`${i+1}`,{ x:0.4,y:1.72+i*0.52,w:0.26,h:0.26, fontSize:8,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
    s.addText(g,{ x:0.76,y:1.68+i*0.52,w:4.0,h:0.4, fontSize:11,color:TEXT_M,valign:"middle" });
  });

  // Long-term
  s.addShape(prs.ShapeType.rect,{ x:5.1,y:1.18,w:4.65,h:3.35, fill:{ color:LIGHT }, line:{ color:MID,width:2 } });
  s.addShape(prs.ShapeType.rect,{ x:5.1,y:1.18,w:4.65,h:0.45, fill:{ color:MID } });
  s.addText("LONG-TERM GOALS",{ x:5.25,y:1.18,w:3.2,h:0.45, fontSize:SUB-8,bold:true,color:WHITE,valign:"middle",margin:0 });
  s.addText("3–6 Months",{ x:8.45,y:1.18,w:1.2,h:0.45, fontSize:SMALL,color:LIGHT,align:"right",valign:"middle",margin:0 });
  ["Achieve PASI-75 or PASI-90 response","Prevent future flare-ups","Improve quality of life",
   "Maintain long-term disease control","Minimize treatment-related toxicity"].forEach((g,i)=>{
    s.addShape(prs.ShapeType.ellipse,{ x:5.27,y:1.72+i*0.52,w:0.26,h:0.26, fill:{ color:MID } });
    s.addText(`${i+1}`,{ x:5.27,y:1.72+i*0.52,w:0.26,h:0.26, fontSize:8,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
    s.addText(g,{ x:5.63,y:1.68+i*0.52,w:4.0,h:0.4, fontSize:11,color:TEXT_M,valign:"middle" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 13 – NON-PHARMACOLOGICAL MANAGEMENT
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"NON-PHARMACOLOGICAL MANAGEMENT","Lifestyle & Supportive Interventions");
  footer(s,13,"Non-Pharmacological Management");

  const items=[
    { title:"Regular Moisturization", shade:DARK,
      text:"Apply emollients (petroleum jelly, paraffin, ceramide creams) 3–4 times daily to reduce dryness, scaling, and itching." },
    { title:"Proper Skin Care",       shade:MID,
      text:"Lukewarm water for bathing; avoid hot showers and harsh soaps; pat dry and apply moisturizer immediately after." },
    { title:"Stress Management",      shade:DARK,
      text:"Practice yoga, meditation, deep breathing, and ensure adequate sleep to reduce flare triggers." },
    { title:"Avoid Skin Trauma",      shade:MID,
      text:"Avoid scratching, rubbing, and tight clothing to prevent the Koebner phenomenon." },
    { title:"Lifestyle Modification", shade:DARK,
      text:"Stop smoking, limit alcohol consumption, and maintain a healthy body weight." },
    { title:"Regular Exercise",       shade:MID,
      text:"Moderate physical activity to improve overall health and reduce psychological stress." },
    { title:"Avoid Triggers",         shade:DARK,
      text:"Avoid stress, skin injury, infections, and medications that may worsen psoriasis symptoms." },
    { title:"Patient Education",      shade:MID,
      text:"Psoriasis is a chronic, non-contagious disease requiring long-term management and treatment adherence." },
  ];
  items.forEach((item,i)=>{
    const x=0.25+(i%2)*4.9, y=1.18+Math.floor(i/2)*1.04;
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:0.96, fill:{ color:LIGHT }, line:{ color:item.shade,width:1 } });
    s.addShape(prs.ShapeType.rect,{ x,y,w:0.08,h:0.96, fill:{ color:item.shade } });
    s.addText(item.title,{ x:x+0.16,y:y+0.04,w:4.3,h:0.3, fontSize:SMALL+1,bold:true,color:item.shade,margin:0 });
    s.addText(item.text,{ x:x+0.16,y:y+0.37,w:4.3,h:0.56, fontSize:SMALL,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 14 – PHARMACOLOGICAL TREATMENT
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PHARMACOLOGICAL TREATMENT REGIMEN","Drug Therapy Plan");
  footer(s,14,"Pharmacological Treatment Regimen");

  const rxData=[
    ["Inj. Secukinumab",                "300 mg","SC",    "Wks 0,1,2,3,4 → q4w",       "Long-term maintenance"],
    ["Tab. Cyclosporine",               "75 mg", "PO",    "Twice daily",                 "4–8 wks → taper after biologic response"],
    ["Clobetasol Propionate 0.05% Oint.","–",    "Topical","Twice daily",                "2–4 weeks"],
    ["Clobetasol 0.05% Scalp Solution", "–",     "Topical","Once daily",                 "2–4 weeks"],
    ["Calcipotriol 0.005% Ointment",    "–",     "Topical","Twice daily",                "Long-term maintenance"],
    ["Tab. Cetirizine",                 "10 mg", "PO",    "Once daily (bedtime)",        "2–4 wks or until resolved"],
    ["Emollients / Moisturizers",       "–",     "Topical","3–4 times daily",            "Continuous / Long-term"],
  ];
  const cols=["DRUG","DOSE","ROA","FREQUENCY","DURATION"];
  const cw=[2.7,0.7,0.6,2.4,3.1];
  let cx=0.25;

  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.42, fill:{ color:DARK } });
  cols.forEach((c,ci)=>{
    s.addText(c,{ x:cx+0.06,y:1.18,w:cw[ci]-0.06,h:0.42, fontSize:SMALL,bold:true,color:WHITE,valign:"middle",margin:0 });
    cx+=cw[ci];
  });

  // Alternate row shading: white / LIGHT
  const leftShades=[DARK,MID,DARK,MID,DARK,MID,DARK];
  rxData.forEach((row,ri)=>{
    const ry=1.6+ri*0.54;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:9.5,h:0.52, fill:{ color:ri%2===0?WHITE:LIGHT }, line:{ color:LIGHT,width:0.5 } });
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:0.05,h:0.52, fill:{ color:leftShades[ri] } });
    let rcx=0.25;
    row.forEach((cell,ci)=>{
      s.addText(cell,{ x:rcx+0.08,y:ry,w:cw[ci]-0.08,h:0.52, fontSize:SMALL,bold:ci===0,color:ci===0?DARK:TEXT_M,valign:"middle",margin:0 });
      rcx+=cw[ci];
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 15 – MONITORING
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"CLINICAL MONITORING FRAMEWORK","Efficacy & Safety Parameters");
  footer(s,15,"Clinical Monitoring Framework");

  // Efficacy card (left)
  card(s,0.25,1.18,4.65,2.72,"EFFICACY MONITORING");
  ["Reduction in redness (erythema)","Reduction in scaling",
   "Reduction in itching (pruritus)","Decrease in plaque thickness",
   "Improvement in BSA and PASI score","Fewer flare-ups, better quality of life"
  ].forEach((e,i)=>{
    s.addText("✓  "+e,{ x:0.4,y:1.62+i*0.36,w:4.35,h:0.33, fontSize:SMALL+0.5,color:TEXT_M,margin:0 });
  });

  // Safety cards (right)
  const safety=[
    { title:"Cyclosporine", shade:DARK,
      items:["Blood pressure","Serum creatinine (SCr)","BUN & electrolytes (K⁺)","Uric acid"] },
    { title:"Secukinumab (Biologic)", shade:MID,
      items:["Signs of infection","TB screening pre-treatment","CBC, LFT, RFT periodically"] },
    { title:"Topical Corticosteroids", shade:DARK,
      items:["Skin atrophy","Striae (stretch marks)","Local skin irritation"] },
  ];
  safety.forEach((item,i)=>{
    const y=1.18+i*1.0;
    s.addShape(prs.ShapeType.rect,{ x:5.1,y,w:4.65,h:0.92, fill:{ color:LIGHT }, line:{ color:item.shade,width:1 } });
    s.addShape(prs.ShapeType.rect,{ x:5.1,y,w:4.65,h:0.36, fill:{ color:item.shade } });
    s.addText(item.title,{ x:5.22,y,w:4.4,h:0.36, fontSize:SMALL+0.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    item.items.forEach((t,ti)=>{
      s.addText("⚠  "+t,{ x:5.22,y:y+0.4+ti*0.19,w:4.4,h:0.18, fontSize:SMALL,color:TEXT_M,margin:0 });
    });
  });

  // Follow-up
  card(s,5.1,4.18,4.65,0.72,"FOLLOW-UP SCHEDULE");
  s.addText("Review every 4–8 weeks to assess treatment response and adverse effects.",{
    x:5.25,y:4.56,w:4.4,h:0.3, fontSize:SMALL+0.5,color:TEXT_M
  });

  // PASI target bar
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:5.0,w:9.5,h:0.4, fill:{ color:DARK } });
  s.addText("TARGET:  PASI-75 by Week 16   |   PASI-90 by Month 6   |   Sustained PASI-90 for long-term maintenance",{
    x:0.4,y:5.0,w:9.1,h:0.4, fontSize:10,bold:true,color:WHITE,align:"center",valign:"middle"
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 16 – PATIENT COUNSELLING PART 1
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PATIENT COUNSELLING","Part 1 – Disease Education & Medication");
  footer(s,16,"Patient Counselling – Part 1");

  // Disease education
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.95, fill:{ color:LIGHT }, line:{ color:MID,width:1.5 } });
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.36, fill:{ color:MID } });
  s.addText("DISEASE EDUCATION",{ x:0.4,y:1.18,w:9.1,h:0.36, fontSize:SMALL,bold:true,color:WHITE,charSpacing:2,valign:"middle",margin:0 });
  ["Psoriasis is a long-term autoimmune skin disease — it is NOT contagious.",
   "Treatment controls symptoms and prevents flare-ups; it does not permanently cure the disease."
  ].forEach((e,i)=>{
    s.addText("•  "+e,{ x:0.4,y:1.58+i*0.3,w:9.1,h:0.28, fontSize:SMALL+0.5,color:TEXT_M });
  });

  // Medication cards
  const meds=[
    { name:"Cyclosporine", shade:DARK,
      points:["Take regularly as prescribed","Avoid grapefruit juice (↑ drug levels)","Report reduced urine output or swelling","Monitor blood pressure at home regularly"] },
    { name:"Secukinumab (Biologic)", shade:MID,
      points:["Store injection in refrigerator (2–8°C)","Rotate injection site each time","Report fever, cough, or signs of infection","Do not miss doses — follow schedule strictly"] },
  ];
  meds.forEach((m,i)=>{
    const x=0.25+i*4.9;
    s.addShape(prs.ShapeType.rect,{ x,y:2.28,w:4.65,h:2.85, fill:{ color:LIGHT }, line:{ color:m.shade,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x,y:2.28,w:4.65,h:0.42, fill:{ color:m.shade } });
    s.addText(m.name,{ x:x+0.12,y:2.28,w:4.4,h:0.42, fontSize:11,bold:true,color:WHITE,valign:"middle",margin:0 });
    m.points.forEach((p,pi)=>{
      s.addText("→  "+p,{ x:x+0.15,y:2.74+pi*0.56,w:4.35,h:0.52, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle" });
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 17 – PATIENT COUNSELLING PART 2 + THANK YOU
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PATIENT COUNSELLING","Part 2 – Topical Steroids & Lifestyle");
  footer(s,17,"Patient Counselling – Part 2");

  // Topical steroids
  card(s,0.25,1.18,4.65,2.0,"TOPICAL STEROIDS");
  ["Apply only a thin layer to affected areas",
   "Do not use longer than prescribed",
   "Wash hands after applying medication",
   "Do not apply to face unless specifically directed"
  ].forEach((p,i)=>{
    s.addText("→  "+p,{ x:0.4,y:1.62+i*0.37,w:4.4,h:0.34, fontSize:SMALL+0.5,color:TEXT_M });
  });

  // Lifestyle card
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:3.32,w:4.65,h:1.82, fill:{ color:LIGHT }, line:{ color:MID,width:1.5 } });
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:3.32,w:4.65,h:0.42, fill:{ color:MID } });
  s.addText("LIFESTYLE COUNSELLING",{ x:0.4,y:3.32,w:4.4,h:0.42, fontSize:11,bold:true,color:WHITE,valign:"middle",margin:0 });
  ["Use moisturizers daily to keep skin hydrated",
   "Avoid scratching the lesions",
   "Manage stress through relaxation techniques and adequate sleep",
   "Stop smoking and limit alcohol intake"
  ].forEach((p,i)=>{
    s.addText("✓  "+p,{ x:0.4,y:3.78+i*0.34,w:4.4,h:0.31, fontSize:SMALL+0.5,color:TEXT_M });
  });

  // Thank you panel
  s.addShape(prs.ShapeType.rect,{ x:5.1,y:1.18,w:4.65,h:3.96, fill:{ color:DARK }, line:{ color:MID,width:2 } });
  // decorative circle
  s.addShape(prs.ShapeType.ellipse,{ x:5.5,y:0.9,w:3.2,h:3.2, fill:{ color:MID,transparency:88 } });

  s.addText("Thank You",{ x:5.2,y:1.55,w:4.4,h:0.9, fontSize:34,bold:true,color:WHITE,align:"center" });
  s.addShape(prs.ShapeType.line,{ x:5.65,y:2.52,w:3.4,h:0, line:{ color:MID,width:2 } });
  s.addText("Questions & Discussion",{ x:5.2,y:2.6,w:4.4,h:0.42, fontSize:14,color:LIGHT,align:"center",italic:true });

  // Summary box
  s.addShape(prs.ShapeType.rect,{ x:5.28,y:3.15,w:4.3,h:1.6, fill:{ color:"072435" }, line:{ color:MID,width:1 } });
  s.addText("CASE SUMMARY",{ x:5.4,y:3.2,w:4.0,h:0.28, fontSize:SMALL,bold:true,color:LIGHT,charSpacing:3,align:"center" });
  s.addText(
    "50M  ·  Severe Plaque Psoriasis\n27-yr refractory disease\nRec: Secukinumab + Cyclosporine bridge\n+ Topicals + Cetirizine + Emollients",
    { x:5.4,y:3.52,w:4.0,h:1.16, fontSize:SMALL+0.5,color:WHITE,align:"center" }
  );
}

// ─── WRITE ────────────────────────────────────────────────────────
prs.writeFile({ fileName:"/home/daytona/workspace/plaque-psoriasis-ppt/Plaque_Psoriasis_Monochrome_Teal.pptx" })
  .then(()=>console.log("SUCCESS"))
  .catch(e=>{ console.error("ERROR:",e); process.exit(1); });

Running Command

cd /home/daytona/workspace/plaque-psoriasis-ppt && node build_mono.js 2>&1

Running Command

ls -lh /home/daytona/workspace/plaque-psoriasis-ppt/Plaque_Psoriasis_Monochrome_Teal.pptx

Your monochromatic presentation is ready:

Plaque Psoriasis Monochrome Teal

Presentation · PPTX

Three shades used throughout — exclusively teal:

Shade	Hex	Used for
Dark Teal `■`	`#0B4F6C`	Header bars, primary cards, table titles, DTP odd cards
Mid Teal `■`	`#1A8A9B`	Divider strips, sub-cards, table sub-headers, even cards
Pale Teal `■`	`#D6F0F4`	Slide backgrounds, card fills, alt table rows, chips

Design rules applied:

White slide backgrounds with pale teal card fills — clean and light
Headlines at 28 pt bold, sub-headlines at 24 pt italic on every slide
Dark/mid teal alternate on header bars, DTP cards, and table stripes for visual rhythm
No other colours used anywhere — purely monochromatic
17 slides covering all content from the uploaded file

Provide

It looks like your message got cut off! Could you complete your request?

Asking for Preferences

What would you like me to provide?

Asking for Preferences

Which colour family would you like for the three-shade monochromatic theme?

Three shades of Blue / Indigo — building it now.

Writing File

~/plaque-psoriasis-ppt/build_blue.js

const pptxgen = require("pptxgenjs");

const prs = new pptxgen();
prs.layout  = "LAYOUT_16x9";
prs.title   = "Plaque Psoriasis Case Study";
prs.author  = "Ganavi C";

// ─── THREE SHADES OF BLUE / INDIGO ────────────────────────────────
const DARK   = "1A237E";   // deep indigo  – headers, primary strips
const MID    = "3F51B5";   // mid blue     – cards, bands, chips
const LIGHT  = "E8EAF6";   // pale lavender-blue – backgrounds, alt rows

const WHITE  = "FFFFFF";
const TEXT_D = "1A237E";   // deep indigo for bold text
const TEXT_M = "283593";   // mid-dark indigo for body text

// Font sizes
const HEAD  = 28;
const SUB   = 24;
const BODY  = 11;
const SMALL = 9.5;

// ─── HELPERS ──────────────────────────────────────────────────────
function bgLight(slide) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:0, w:10, h:5.625, fill:{ color:WHITE } });
}

function titleBar(slide, headline, sub) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:0,    w:10, h:1.05, fill:{ color:DARK } });
  slide.addShape(prs.ShapeType.rect, { x:0, y:1.05, w:10, h:0.06, fill:{ color:MID  } });
  slide.addText(headline, {
    x:0.35, y:0.04, w:9.3, h:0.62,
    fontSize:HEAD, bold:true, color:WHITE, valign:"bottom", margin:0
  });
  if (sub) {
    slide.addText(sub, {
      x:0.35, y:0.66, w:9.3, h:0.36,
      fontSize:SUB, color:LIGHT, valign:"top", italic:true, margin:0
    });
  }
}

function footer(slide, num, label) {
  slide.addShape(prs.ShapeType.rect, { x:0, y:5.43, w:10, h:0.195, fill:{ color:DARK } });
  slide.addText(`Slide ${num}  ·  ${label}`, {
    x:0.2, y:5.43, w:5, h:0.195, fontSize:7.5, color:LIGHT, valign:"middle", margin:0
  });
  slide.addText("Plaque Psoriasis Case  ·  Ganavi C  ·  V Pharm D  ·  21Q0275", {
    x:5, y:5.43, w:4.8, h:0.195, fontSize:7.5, color:LIGHT, align:"right", valign:"middle", margin:0
  });
}

function card(slide, x, y, w, h, title, hdrShade) {
  const hdr = hdrShade || MID;
  slide.addShape(prs.ShapeType.rect, {
    x, y, w, h, fill:{ color:LIGHT }, line:{ color:hdr, width:1 }
  });
  if (title) {
    slide.addShape(prs.ShapeType.rect, { x, y, w, h:0.38, fill:{ color:hdr } });
    slide.addText(title, {
      x:x+0.12, y, w:w-0.2, h:0.38,
      fontSize:SMALL+1, bold:true, color:WHITE, valign:"middle", charSpacing:1, margin:0
    });
  }
}

function labTable(slide, x, y, w, title, rows) {
  const HDR_H = 0.36, COL_H = 0.38;
  const cw = [w*0.44, w*0.28, w*0.28];

  slide.addShape(prs.ShapeType.rect, { x, y, w, h:HDR_H, fill:{ color:DARK } });
  slide.addText(title, { x:x+0.1, y, w:w-0.15, h:HDR_H, fontSize:SMALL+1, bold:true, color:WHITE, valign:"middle", margin:0 });

  const sy = y + HDR_H;
  slide.addShape(prs.ShapeType.rect, { x, y:sy, w, h:HDR_H, fill:{ color:MID } });
  let cx = x;
  ["Parameter","Result","Normal Range"].forEach((h,ci)=>{
    slide.addText(h, { x:cx+0.06, y:sy, w:cw[ci]-0.06, h:HDR_H, fontSize:SMALL, bold:true, color:WHITE, valign:"middle", margin:0 });
    cx += cw[ci];
  });

  rows.forEach((row,ri)=>{
    const ry = sy + HDR_H + ri*COL_H;
    const fill = ri%2===0 ? WHITE : LIGHT;
    slide.addShape(prs.ShapeType.rect, { x, y:ry, w, h:COL_H, fill:{ color:fill }, line:{ color:LIGHT, width:0.5 } });
    let rcx = x;
    row.slice(0,3).forEach((cell,ci)=>{
      const isLow = row[3]==="L" || (typeof cell==="string" && cell.toLowerCase().includes("low"));
      const tc = ci===0 ? TEXT_D : (ci===1 && isLow) ? MID : TEXT_M;
      slide.addText(cell, { x:rcx+0.06, y:ry, w:cw[ci]-0.06, h:COL_H, fontSize:SMALL, bold:ci===0, color:tc, valign:"middle", margin:0 });
      rcx += cw[ci];
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 1 – TITLE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide();
  s.addShape(prs.ShapeType.rect, { x:0,y:0,w:10,h:5.625, fill:{ color:WHITE } });
  // Left panel – deep indigo
  s.addShape(prs.ShapeType.rect, { x:0,y:0,w:3.8,h:5.625, fill:{ color:DARK } });
  // Divider – mid blue
  s.addShape(prs.ShapeType.rect, { x:3.8,y:0,w:0.07,h:5.625, fill:{ color:MID } });
  // Decorative circles
  s.addShape(prs.ShapeType.ellipse, { x:-1.1,y:-1.0,w:4.2,h:4.2, fill:{ color:MID, transparency:82 } });
  s.addShape(prs.ShapeType.ellipse, { x:0.4,y:3.85,w:2.8,h:2.8, fill:{ color:LIGHT, transparency:68 } });

  // Left panel
  s.addText("CASE\nSTUDY", {
    x:0.15,y:0.5,w:3.5,h:1.5, fontSize:36,bold:true,color:WHITE,align:"center",charSpacing:7
  });
  s.addShape(prs.ShapeType.line, { x:0.55,y:2.1,w:2.6,h:0, line:{ color:MID,width:2 } });
  s.addText("Dermatology &\nClinical Pharmacy", {
    x:0.15,y:2.23,w:3.5,h:0.7, fontSize:13,color:LIGHT,align:"center",italic:true
  });

  // Presenter box
  s.addShape(prs.ShapeType.rect, { x:0.28,y:3.3,w:3.2,h:1.65, fill:{ color:"0D1454" }, line:{ color:MID,width:1 } });
  s.addText("PRESENTED BY", { x:0.38,y:3.37,w:3.0,h:0.28, fontSize:8,bold:true,color:LIGHT,align:"center",charSpacing:3,margin:0 });
  s.addText([
    { text:"Ganavi C\n",       options:{ bold:true, fontSize:15 } },
    { text:"V Pharm D\n",      options:{ fontSize:12 } },
    { text:"Reg No: 21Q0275",  options:{ fontSize:10, color:LIGHT } }
  ], { x:0.38,y:3.68,w:3.0,h:1.05, color:WHITE, align:"center" });

  // Right – main title
  s.addText("Plaque Psoriasis", { x:4.1,y:0.58,w:5.65,h:1.05, fontSize:HEAD+10,bold:true,color:DARK });
  s.addText("Clinical Case Study",  { x:4.1,y:1.65,w:5.65,h:0.52, fontSize:SUB,color:MID,italic:true });
  s.addShape(prs.ShapeType.line, { x:4.1,y:2.25,w:5.2,h:0, line:{ color:MID,width:2 } });

  // Tags – dark / mid alternating
  const tags = [
    { t:"Severe",             fill:DARK },
    { t:"Chronic",            fill:MID  },
    { t:"Uncontrolled",       fill:DARK },
    { t:"Biologic Candidate", fill:MID  },
  ];
  tags.forEach((tg,i)=>{
    s.addShape(prs.ShapeType.roundRect, { x:4.1+i*1.42,y:2.38,w:1.34,h:0.33, fill:{ color:tg.fill }, rectRadius:0.05 });
    s.addText(tg.t, { x:4.1+i*1.42,y:2.38,w:1.34,h:0.33, fontSize:8,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
  });

  s.addText(
    "A 50-year-old male with a 27-year history of plaque psoriasis\npresenting with severe, uncontrolled disease despite multiple lines of therapy.",
    { x:4.1,y:2.85,w:5.65,h:0.8, fontSize:10.5,color:TEXT_M,italic:true }
  );

  // Bottom bar – pale
  s.addShape(prs.ShapeType.rect, { x:0,y:5.43,w:10,h:0.195, fill:{ color:LIGHT } });
  s.addText("V Pharm D  ·  Clinical Pharmacy Case Presentation  ·  2024", {
    x:0,y:5.43,w:10,h:0.195, fontSize:8.5,color:DARK,align:"center",valign:"middle"
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 2 – PATIENT PROFILE
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"SUBJECTIVE DATA","Patient Profile");
  footer(s,2,"Subjective Data – Patient Profile");

  card(s,0.25,1.18,4.55,3.35,"PATIENT INFORMATION",DARK);
  const patRows=[["Age","50 years"],["Gender","Male"],["Occupation","Elementary School Teacher"],["Weight","75 kg"],["Height","5'9\""],["Allergies","NKA"]];
  patRows.forEach(([k,v],i)=>{
    const ry=1.6+i*0.47;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:4.55,h:0.44, fill:{ color:i%2===0?WHITE:LIGHT } });
    s.addText(k,{ x:0.38,y:ry,w:1.85,h:0.44, fontSize:SMALL+0.5,bold:true,color:DARK,valign:"middle",margin:0 });
    s.addText(v,{ x:2.25,y:ry,w:2.42,h:0.44, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle",margin:0 });
  });

  // Chief complaint
  s.addShape(prs.ShapeType.rect,{ x:5.05,y:1.18,w:4.7,h:1.12, fill:{ color:LIGHT }, line:{ color:DARK,width:2 } });
  s.addShape(prs.ShapeType.rect,{ x:5.05,y:1.18,w:4.7,h:0.36, fill:{ color:DARK } });
  s.addText("CHIEF COMPLAINT",{ x:5.18,y:1.18,w:4.4,h:0.36, fontSize:SMALL,bold:true,color:WHITE,valign:"middle",charSpacing:2,margin:0 });
  s.addText('"Nothing is helping my psoriasis."',{ x:5.18,y:1.57,w:4.4,h:0.68, fontSize:13.5,color:DARK,italic:true,valign:"middle" });

  card(s,5.05,2.44,4.7,2.09,"CLINICAL NOTE",MID);
  s.addText(
    "Subjective data emphasizes significant mental burden and clinical therapeutic non-response to conventional treatment routes.\n\nPatient presents with clear frustration after years of escalating treatment without adequate disease control.",
    { x:5.18,y:2.87,w:4.45,h:1.6, fontSize:SMALL+0.5,color:TEXT_M }
  );
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 3 – HPI PART 1
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"HISTORY OF PRESENT ILLNESS","27-Year Treatment Chronology – Part 1");
  footer(s,3,"HPI – Treatment Timeline Part 1");

  s.addText("Chronological course of medical interventions since early diagnosis:",{ x:0.3,y:1.18,w:9.4,h:0.28, fontSize:SMALL+1,color:TEXT_M,italic:true });

  const events=[
    { label:"Initial Diagnosis",    age:"Age 23",             hdr:DARK, bg:LIGHT,
      text:"Plaque psoriasis diagnosed. Good initial control with medium-potency topical corticosteroids." },
    { label:"Combination Course",   age:"Mid-course",         hdr:MID,  bg:WHITE,
      text:"Calcipotriol therapy added when topical corticosteroids alone became insufficient." },
    { label:"Phototherapy Run",     age:"Disease progression",hdr:DARK, bg:LIGHT,
      text:"PUVA (Psoralen + UVA) phototherapy initiated — provided temporary improvement." },
    { label:"Efficacy Loss",        age:"Later",              hdr:MID,  bg:WHITE,
      text:"PUVA gradually lost effectiveness, resulting in inadequate control and recurrent lesions." },
  ];
  events.forEach((e,i)=>{
    const x=0.25+(i%2)*4.9, y=i<2?1.58:3.2;
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:1.48, fill:{ color:e.bg }, line:{ color:e.hdr,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:0.42, fill:{ color:e.hdr } });
    s.addText(e.label,{ x:x+0.12,y,w:3.1,h:0.42, fontSize:SMALL+1.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(e.age, { x:x+3.2, y,w:1.28,h:0.42, fontSize:SMALL,color:LIGHT,align:"right",valign:"middle",margin:0 });
    s.addText(e.text,{ x:x+0.12,y:y+0.48,w:4.35,h:0.96, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 4 – HPI PART 2
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"HISTORY OF PRESENT ILLNESS","27-Year Treatment Chronology – Part 2");
  footer(s,4,"HPI – Treatment Timeline Part 2");

  const events=[
    { label:"Systemic Methotrexate Escalation",        hdr:DARK, bg:LIGHT,
      left:"Frequent flare-ups despite increasing MTX doses — SCAT used for acute exacerbations.",
      right:"MTX escalated to 25 mg/week. Cumulative lifetime dose reached 2.2 g." },
    { label:"Switch: Cyclosporine + Acitretin",         hdr:MID,  bg:WHITE,
      left:"Treatment changed to cyclosporine 75 mg twice daily + acitretin 25 mg daily.",
      right:"Acitretin discontinued due to severe xerosis (drug-induced dry skin)." },
    { label:"Current Presentation — 3rd Severe Flare",  hdr:DARK, bg:LIGHT,
      left:"Cyclosporine alone provided good control for 1 year after acitretin was stopped.",
      right:"Two severe flares in past 6 months. Current = 3rd and most severe presentation." },
  ];
  events.forEach((e,i)=>{
    const y=1.22+i*1.35;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y,w:9.5,h:1.22, fill:{ color:e.bg }, line:{ color:e.hdr,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x:0.25,y,w:9.5,h:0.4, fill:{ color:e.hdr } });
    s.addText(`${i+1}.  ${e.label}`,{ x:0.4,y,w:9.1,h:0.4, fontSize:11,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText("•  "+e.left, { x:0.4, y:y+0.44,w:4.55,h:0.73, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
    s.addText("•  "+e.right,{ x:5.1, y:y+0.44,w:4.5, h:0.73, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 5 – HISTORY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"MEDICAL, FAMILY & SOCIAL HISTORY","Background & Risk Factors");
  footer(s,5,"Medical / Family / Social History");

  card(s,0.25,1.18,4.55,2.4,"MEDICAL & FAMILY HISTORY",DARK);
  [["PMH","Major depressive episode — 16 years ago"],["Brother","Has psoriasis"],["Father","Hypertension + Type 2 Diabetes"]].forEach(([k,v],i)=>{
    const ry=1.62+i*0.6;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:4.55,h:0.56, fill:{ color:i%2===0?WHITE:LIGHT } });
    s.addText(k,{ x:0.38,y:ry,w:1.1,h:0.56, fontSize:SMALL,bold:true,color:DARK,valign:"middle",margin:0 });
    s.addText(v,{ x:1.5,y:ry,w:3.15,h:0.56, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle" });
  });

  card(s,5.05,1.18,4.7,2.4,"SOCIAL PROFILE & TRIGGERS",MID);
  [["Smoking","Former heavy smoker"],["Alcohol","One glass of wine daily"],["Stress","Increased occupational stress"],["Family","Married with children"]].forEach(([k,v],i)=>{
    const ry=1.62+i*0.48;
    s.addShape(prs.ShapeType.rect,{ x:5.05,y:ry,w:4.7,h:0.44, fill:{ color:i%2===0?WHITE:LIGHT } });
    s.addText(k,{ x:5.18,y:ry,w:1.2,h:0.44, fontSize:SMALL,bold:true,color:DARK,valign:"middle",margin:0 });
    s.addText(v,{ x:6.4,y:ry, w:3.2,h:0.44, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle" });
  });

  card(s,0.25,3.72,4.55,0.95,"ALLERGIES & TOLERABILITY",DARK);
  s.addText("NKA  —  No Known Allergies",{ x:0.4,y:4.14,w:4.3,h:0.28, fontSize:SMALL+1,bold:true,color:DARK });
  s.addText("Drug intolerance: Acitretin — severe xerosis confirmed",{ x:0.4,y:4.42,w:4.3,h:0.22, fontSize:SMALL,color:TEXT_M });

  card(s,5.05,3.72,4.7,0.95,"RISK AMPLIFIERS",MID);
  s.addText("Smoking, alcohol, and occupational stress are established psoriasis flare triggers and may contribute to treatment resistance.",{
    x:5.18,y:4.12,w:4.45,h:0.5, fontSize:SMALL+0.5,color:TEXT_M
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 6 – OBJECTIVE DATA
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"OBJECTIVE DATA","Vital Signs & Physical Examination");
  footer(s,6,"Objective Data – Vitals & Skin Exam");

  const vitals=[
    { label:"BLOOD PRESSURE",val:"129/83",unit:"mmHg",       col:DARK },
    { label:"PULSE RATE",    val:"88",    unit:"bpm",        col:MID  },
    { label:"TEMPERATURE",  val:"37°C",  unit:"Normal",     col:DARK },
    { label:"APPEARANCE",   val:"Alert", unit:"Mild anxiety",col:MID  },
  ];
  vitals.forEach((v,i)=>{
    const x=0.25+i*2.42;
    s.addShape(prs.ShapeType.rect,{ x,y:1.18,w:2.3,h:1.25, fill:{ color:LIGHT }, line:{ color:v.col,width:2 } });
    s.addShape(prs.ShapeType.rect,{ x,y:1.18,w:2.3,h:0.36, fill:{ color:v.col } });
    s.addText(v.label,{ x:x+0.07,y:1.18,w:2.16,h:0.36, fontSize:7.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(v.val,  { x:x+0.07,y:1.56,w:2.16,h:0.52, fontSize:22,bold:true,color:v.col,align:"center" });
    s.addText(v.unit, { x:x+0.07,y:2.09,w:2.16,h:0.3,  fontSize:SMALL,color:TEXT_M,align:"center" });
  });

  s.addShape(prs.ShapeType.rect,{ x:0.25,y:2.57,w:9.5,h:2.62, fill:{ color:LIGHT }, line:{ color:DARK,width:1.5 } });
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:2.57,w:9.5,h:0.42, fill:{ color:DARK } });
  s.addText("SKIN EXAMINATION — Severe Plaque Psoriasis",{ x:0.4,y:2.57,w:9.15,h:0.42, fontSize:11,bold:true,color:WHITE,valign:"middle",charSpacing:1,margin:0 });

  const locs=["Abdomen","Arms","Legs","Back","Scalp","Palms","Soles","Elbows","Knees"];
  s.addText("Locations:",{ x:0.4,y:3.06,w:1.3,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  locs.forEach((loc,i)=>{
    const lx=1.65+i*0.86;
    s.addShape(prs.ShapeType.roundRect,{ x:lx,y:3.06,w:0.8,h:0.28, fill:{ color:MID }, rectRadius:0.04 });
    s.addText(loc,{ x:lx,y:3.06,w:0.8,h:0.28, fontSize:7.5,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
  });
  s.addText("Visual Profile:",   { x:0.4,y:3.44,w:1.6,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  s.addText("Thick plaques  ·  Erythematous lesions  ·  Well-demarcated borders  ·  Confluent lesions",{ x:1.95,y:3.44,w:7.55,h:0.28, fontSize:SMALL+0.5,color:TEXT_M,margin:0 });
  s.addText("Secondary Signs:",  { x:0.4,y:3.78,w:1.8,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  s.addText("Silvery-white scales  ·  Excoriations due to scratching",{ x:2.2,y:3.78,w:7.3,h:0.28, fontSize:SMALL+0.5,color:TEXT_M,margin:0 });
  s.addText("General Status:",   { x:0.4,y:4.12,w:1.8,h:0.28, fontSize:SMALL,bold:true,color:DARK,margin:0 });
  s.addText("Alert, oriented  ·  Mild anxiety noted",{ x:2.2,y:4.12,w:7.3,h:0.28, fontSize:SMALL+0.5,color:TEXT_M,margin:0 });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 7 – LAB: CBC & RENAL
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"LABORATORY DATA","Complete Blood Count & Renal Panel");
  footer(s,7,"Lab Data – CBC & Renal");

  labTable(s,0.25,1.18,9.5,"COMPLETE BLOOD COUNT (CBC)",[
    ["Hemoglobin (Hb)",  "13.5 g/dL",       "13.5–17.5 g/dL","N"],
    ["Hematocrit (Hct)", "35% (Mildly Low)", "40–52%",        "L"],
    ["WBC",              "6.0 ×10³/mm³",     "4–11 ×10³/mm³", "N"],
    ["Platelets",        "255 ×10³/mm³",     "150–400 ×10³/mm³","N"],
  ]);
  labTable(s,0.25,3.72,9.5,"RENAL FUNCTION TEST (RFT)",[
    ["Blood Urea Nitrogen (BUN)","14 mg/dL","7–20 mg/dL",   "N"],
    ["Creatinine (SCr)",         "1.0 mg/dL","0.6–1.3 mg/dL","N"],
  ]);
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:5.17,w:9.5,h:0.25, fill:{ color:LIGHT }, line:{ color:MID,width:0.75 } });
  s.addText("⚠  Hematocrit (35%) is mildly below normal (40–52%) — monitor for mild anemia.",{ x:0.4,y:5.17,w:9.2,h:0.25, fontSize:8.5,color:DARK,valign:"middle",margin:0 });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 8 – LAB: LFT
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"LABORATORY DATA","Liver Function Profile");
  footer(s,8,"Lab Data – Liver Function");

  labTable(s,0.25,1.18,9.5,"LIVER FUNCTION TEST (LFT)",[
    ["AST (SGOT)",               "22 IU/L",  "10–40 IU/L",   "N"],
    ["ALT (SGPT)",               "38 IU/L",  "7–56 IU/L",    "N"],
    ["Alkaline Phosphatase (ALP)","98 IU/L", "44–147 IU/L",  "N"],
    ["Total Bilirubin",          "1.0 mg/dL","0.1–1.2 mg/dL","N"],
    ["Albumin",                  "3.7 g/dL", "3.5–5.0 g/dL", "N"],
  ]);

  card(s,0.25,4.1,9.5,1.02,"CLINICAL INTERPRETATION",MID);
  s.addText(
    "All liver function parameters are within normal limits — clinically significant given the patient's history of methotrexate use (cumulative dose 2.2 g). Normal LFTs support safe transition to biologic therapy (Secukinumab).",
    { x:0.4,y:4.52,w:9.2,h:0.55, fontSize:SMALL+0.5,color:TEXT_M }
  );
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 9 – LAB: ELECTROLYTES & CHEMISTRY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"LABORATORY DATA","Electrolytes & Chemistry Panel");
  footer(s,9,"Lab Data – Electrolytes & Chemistry");

  labTable(s,0.25,1.18,9.5,"ELECTROLYTES & CHEMISTRY",[
    ["Sodium (Na⁺)",            "139 mEq/L","135–145 mEq/L","N"],
    ["Potassium (K⁺)",          "4.0 mEq/L","3.5–5.0 mEq/L","N"],
    ["Chloride (Cl⁻)",          "102 mEq/L","98–106 mEq/L", "N"],
    ["Bicarbonate (HCO₃⁻/CO₂)","25 mEq/L", "22–28 mEq/L",  "N"],
    ["Uric Acid",               "4 mg/dL",  "3.5–7.2 mg/dL","N"],
    ["Total Cholesterol",       "180 mg/dL","<200 mg/dL",   "N"],
    ["Blood Glucose",           "98 mg/dL", "70–110 mg/dL", "N"],
  ]);

  card(s,0.25,4.9,9.5,0.68,"CYCLOSPORINE SAFETY NOTE",DARK);
  s.addText("Potassium and renal parameters are within normal limits — important for cyclosporine safety monitoring (hyperkalemia and nephrotoxicity risk).",{
    x:0.4,y:5.18,w:9.2,h:0.35, fontSize:SMALL+0.5,color:TEXT_M
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 10 – ASSESSMENT: DIAGNOSIS & SEVERITY
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"ASSESSMENT","Diagnosis & Severity Profile");
  footer(s,10,"Assessment – Diagnosis & Severity");

  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.62, fill:{ color:DARK } });
  s.addText("PRIMARY DIAGNOSIS",{ x:0.42,y:1.2,w:2.8,h:0.28, fontSize:SMALL,bold:true,color:LIGHT,charSpacing:2,margin:0 });
  s.addText("Severe Chronic Plaque Psoriasis (Uncontrolled)",{ x:0.42,y:1.46,w:9.0,h:0.3, fontSize:14,bold:true,color:WHITE,margin:0 });

  const metrics=[
    { label:"BSA Involvement", val:">20%",   sub:"Severe threshold: >10%", shade:DARK },
    { label:"Estimated PASI",  val:">20",    sub:"Severe disease index",    shade:MID  },
    { label:"Disease Duration",val:"27 yrs", sub:"Chronic, refractory",     shade:DARK },
  ];
  metrics.forEach((m,i)=>{
    const x=0.25+i*3.25;
    s.addShape(prs.ShapeType.rect,{ x,y:1.95,w:3.1,h:1.25, fill:{ color:LIGHT }, line:{ color:m.shade,width:2 } });
    s.addText(m.label,{ x:x+0.1,y:1.98,w:2.9,h:0.3, fontSize:SMALL,bold:true,color:m.shade,margin:0 });
    s.addText(m.val,  { x:x+0.1,y:2.26,w:2.9,h:0.6, fontSize:28,bold:true,color:m.shade,align:"center" });
    s.addText(m.sub,  { x:x+0.1,y:2.86,w:2.9,h:0.28, fontSize:SMALL-0.5,color:TEXT_M,align:"center" });
  });

  card(s,0.25,3.34,4.65,1.82,"CLINICAL EVIDENCE",DARK);
  ["Erythematous plaques with silvery scales","Extensive body involvement","Long-standing disease (27 years)","Positive family history of psoriasis"].forEach((e,i)=>{
    s.addText("✓  "+e,{ x:0.4,y:3.76+i*0.35,w:4.35,h:0.32, fontSize:SMALL+0.5,color:TEXT_M });
  });

  card(s,5.1,3.34,4.65,1.82,"SEVERITY BENCHMARKS",MID);
  ["BSA Involvement: >20%","Areas: Scalp, Arms, Legs, Abdomen, Back, Palms, Soles","Severity: Severe (>10% BSA)","PASI Score: >20 (Severe disease index)"].forEach((e,i)=>{
    s.addText("•  "+e,{ x:5.25,y:3.76+i*0.35,w:4.35,h:0.32, fontSize:SMALL+0.5,color:TEXT_M });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 11 – ASSESSMENT: DTPS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"ASSESSMENT","Drug Therapy Problems (DTPs)");
  footer(s,11,"Assessment – Drug Therapy Problems");

  const dtps=[
    { num:"DTP 1",title:"Refractory Uncontrolled Status",   shade:DARK, text:"Uncontrolled severe plaque psoriasis despite active cyclosporine therapy." },
    { num:"DTP 2",title:"Subtherapeutic Efficacy",          shade:MID,  text:"Inadequate physiological response to current cyclosporine dosing regimen." },
    { num:"DTP 3",title:"Historical Treatment Failures",    shade:DARK, text:"Previous failures: topical therapy, PUVA phototherapy, and methotrexate." },
    { num:"DTP 4",title:"Adverse Event Intolerance",        shade:MID,  text:"Oral acitretin intolerance due to secondary severe xerosis (dry skin)." },
    { num:"DTP 5",title:"Severe Pruritus Burden",           shade:DARK, text:"Severe pruritus causing chronic scratching and skin excoriations." },
    { num:"DTP 6",title:"Psychosocial Exacerbation",        shade:MID,  text:"Occupational stress contributing to disease flare-ups and worsening." },
  ];
  dtps.forEach((d,i)=>{
    const x=0.25+(i%2)*4.9, y=1.18+Math.floor(i/2)*1.38;
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:1.26, fill:{ color:LIGHT }, line:{ color:d.shade,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:0.42, fill:{ color:d.shade } });
    s.addText(d.num,  { x:x+0.1, y,w:0.75,h:0.42, fontSize:SMALL,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(d.title,{ x:x+0.85,y,w:3.65,h:0.42, fontSize:SMALL+0.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    s.addText(d.text, { x:x+0.12,y:y+0.48,w:4.35,h:0.72, fontSize:SMALL+0.5,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 12 – PLANNING: GOALS
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PLANNING","Goals of Therapy");
  footer(s,12,"Planning – Goals of Therapy");

  // Short-term
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:4.65,h:3.35, fill:{ color:LIGHT }, line:{ color:DARK,width:2 } });
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:4.65,h:0.45, fill:{ color:DARK } });
  s.addText("SHORT-TERM GOALS",{ x:0.4,y:1.18,w:3.2,h:0.45, fontSize:SUB-8,bold:true,color:WHITE,valign:"middle",margin:0 });
  s.addText("4–8 Weeks",       { x:3.6,y:1.18,w:1.2,h:0.45, fontSize:SMALL,color:LIGHT,align:"right",valign:"middle",margin:0 });
  ["Reduce erythema (redness)","Reduce scaling","Relieve itching (pruritus)","Stop disease progression","Improve sleep and comfort"].forEach((g,i)=>{
    s.addShape(prs.ShapeType.ellipse,{ x:0.4,y:1.72+i*0.52,w:0.26,h:0.26, fill:{ color:DARK } });
    s.addText(`${i+1}`,{ x:0.4,y:1.72+i*0.52,w:0.26,h:0.26, fontSize:8,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
    s.addText(g,{ x:0.76,y:1.68+i*0.52,w:4.0,h:0.4, fontSize:11,color:TEXT_M,valign:"middle" });
  });

  // Long-term
  s.addShape(prs.ShapeType.rect,{ x:5.1,y:1.18,w:4.65,h:3.35, fill:{ color:LIGHT }, line:{ color:MID,width:2 } });
  s.addShape(prs.ShapeType.rect,{ x:5.1,y:1.18,w:4.65,h:0.45, fill:{ color:MID } });
  s.addText("LONG-TERM GOALS",{ x:5.25,y:1.18,w:3.2,h:0.45, fontSize:SUB-8,bold:true,color:WHITE,valign:"middle",margin:0 });
  s.addText("3–6 Months",     { x:8.45,y:1.18,w:1.2,h:0.45, fontSize:SMALL,color:LIGHT,align:"right",valign:"middle",margin:0 });
  ["Achieve PASI-75 or PASI-90 response","Prevent future flare-ups","Improve quality of life","Maintain long-term disease control","Minimize treatment-related toxicity"].forEach((g,i)=>{
    s.addShape(prs.ShapeType.ellipse,{ x:5.27,y:1.72+i*0.52,w:0.26,h:0.26, fill:{ color:MID } });
    s.addText(`${i+1}`,{ x:5.27,y:1.72+i*0.52,w:0.26,h:0.26, fontSize:8,bold:true,color:WHITE,align:"center",valign:"middle",margin:0 });
    s.addText(g,{ x:5.63,y:1.68+i*0.52,w:4.0,h:0.4, fontSize:11,color:TEXT_M,valign:"middle" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 13 – NON-PHARMACOLOGICAL
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"NON-PHARMACOLOGICAL MANAGEMENT","Lifestyle & Supportive Interventions");
  footer(s,13,"Non-Pharmacological Management");

  const items=[
    { title:"Regular Moisturization", shade:DARK, text:"Apply emollients (petroleum jelly, paraffin, ceramide creams) 3–4 times daily to reduce dryness, scaling, and itching." },
    { title:"Proper Skin Care",       shade:MID,  text:"Lukewarm water for bathing; avoid hot showers and harsh soaps; pat dry and apply moisturizer immediately after." },
    { title:"Stress Management",      shade:DARK, text:"Practice yoga, meditation, deep breathing, and ensure adequate sleep to reduce flare triggers." },
    { title:"Avoid Skin Trauma",      shade:MID,  text:"Avoid scratching, rubbing, and tight clothing to prevent the Koebner phenomenon." },
    { title:"Lifestyle Modification", shade:DARK, text:"Stop smoking, limit alcohol consumption, and maintain a healthy body weight." },
    { title:"Regular Exercise",       shade:MID,  text:"Moderate physical activity to improve overall health and reduce psychological stress." },
    { title:"Avoid Triggers",         shade:DARK, text:"Avoid stress, skin injury, infections, and medications that may worsen psoriasis symptoms." },
    { title:"Patient Education",      shade:MID,  text:"Psoriasis is a chronic, non-contagious disease requiring long-term management and treatment adherence." },
  ];
  items.forEach((item,i)=>{
    const x=0.25+(i%2)*4.9, y=1.18+Math.floor(i/2)*1.04;
    s.addShape(prs.ShapeType.rect,{ x,y,w:4.6,h:0.96, fill:{ color:LIGHT }, line:{ color:item.shade,width:1 } });
    s.addShape(prs.ShapeType.rect,{ x,y,w:0.08,h:0.96, fill:{ color:item.shade } });
    s.addText(item.title,{ x:x+0.16,y:y+0.04,w:4.3,h:0.3,  fontSize:SMALL+1,bold:true,color:item.shade,margin:0 });
    s.addText(item.text, { x:x+0.16,y:y+0.37,w:4.3,h:0.56, fontSize:SMALL,color:TEXT_M,valign:"top" });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 14 – PHARMACOLOGICAL TREATMENT
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PHARMACOLOGICAL TREATMENT REGIMEN","Drug Therapy Plan");
  footer(s,14,"Pharmacological Treatment Regimen");

  const rxData=[
    ["Inj. Secukinumab",                "300 mg","SC",    "Wks 0,1,2,3,4 → q4w",     "Long-term maintenance"],
    ["Tab. Cyclosporine",               "75 mg", "PO",    "Twice daily",               "4–8 wks → taper after biologic response"],
    ["Clobetasol Propionate 0.05% Oint.","–",    "Topical","Twice daily",              "2–4 weeks"],
    ["Clobetasol 0.05% Scalp Solution", "–",     "Topical","Once daily",               "2–4 weeks"],
    ["Calcipotriol 0.005% Ointment",    "–",     "Topical","Twice daily",              "Long-term maintenance"],
    ["Tab. Cetirizine",                 "10 mg", "PO",    "Once daily (bedtime)",      "2–4 wks or until resolved"],
    ["Emollients / Moisturizers",       "–",     "Topical","3–4 times daily",          "Continuous / Long-term"],
  ];
  const cols=["DRUG","DOSE","ROA","FREQUENCY","DURATION"];
  const cw=[2.7,0.7,0.6,2.4,3.1];
  let cx=0.25;
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.42, fill:{ color:DARK } });
  cols.forEach((c,ci)=>{
    s.addText(c,{ x:cx+0.06,y:1.18,w:cw[ci]-0.06,h:0.42, fontSize:SMALL,bold:true,color:WHITE,valign:"middle",margin:0 });
    cx+=cw[ci];
  });
  rxData.forEach((row,ri)=>{
    const ry=1.6+ri*0.54;
    const leftShade = ri%2===0 ? DARK : MID;
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:9.5,h:0.52, fill:{ color:ri%2===0?WHITE:LIGHT }, line:{ color:LIGHT,width:0.5 } });
    s.addShape(prs.ShapeType.rect,{ x:0.25,y:ry,w:0.05,h:0.52, fill:{ color:leftShade } });
    let rcx=0.25;
    row.forEach((cell,ci)=>{
      s.addText(cell,{ x:rcx+0.08,y:ry,w:cw[ci]-0.08,h:0.52, fontSize:SMALL,bold:ci===0,color:ci===0?DARK:TEXT_M,valign:"middle",margin:0 });
      rcx+=cw[ci];
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 15 – MONITORING
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"CLINICAL MONITORING FRAMEWORK","Efficacy & Safety Parameters");
  footer(s,15,"Clinical Monitoring Framework");

  card(s,0.25,1.18,4.65,2.72,"EFFICACY MONITORING",DARK);
  ["Reduction in redness (erythema)","Reduction in scaling","Reduction in itching (pruritus)",
   "Decrease in plaque thickness","Improvement in BSA and PASI score","Fewer flare-ups, better quality of life"
  ].forEach((e,i)=>{
    s.addText("✓  "+e,{ x:0.4,y:1.62+i*0.36,w:4.35,h:0.33, fontSize:SMALL+0.5,color:TEXT_M,margin:0 });
  });

  [
    { title:"Cyclosporine",             shade:DARK, items:["Blood pressure","Serum creatinine (SCr)","BUN & electrolytes (K⁺)","Uric acid"] },
    { title:"Secukinumab (Biologic)",   shade:MID,  items:["Signs of infection","TB screening pre-treatment","CBC, LFT, RFT periodically"] },
    { title:"Topical Corticosteroids",  shade:DARK, items:["Skin atrophy","Striae (stretch marks)","Local skin irritation"] },
  ].forEach((item,i)=>{
    const y=1.18+i*1.0;
    s.addShape(prs.ShapeType.rect,{ x:5.1,y,w:4.65,h:0.92, fill:{ color:LIGHT }, line:{ color:item.shade,width:1 } });
    s.addShape(prs.ShapeType.rect,{ x:5.1,y,w:4.65,h:0.36, fill:{ color:item.shade } });
    s.addText(item.title,{ x:5.22,y,w:4.4,h:0.36, fontSize:SMALL+0.5,bold:true,color:WHITE,valign:"middle",margin:0 });
    item.items.forEach((t,ti)=>{
      s.addText("⚠  "+t,{ x:5.22,y:y+0.4+ti*0.19,w:4.4,h:0.18, fontSize:SMALL,color:TEXT_M,margin:0 });
    });
  });

  card(s,5.1,4.18,4.65,0.72,"FOLLOW-UP SCHEDULE",MID);
  s.addText("Review every 4–8 weeks to assess treatment response and adverse effects.",{ x:5.25,y:4.56,w:4.4,h:0.3, fontSize:SMALL+0.5,color:TEXT_M });

  s.addShape(prs.ShapeType.rect,{ x:0.25,y:5.0,w:9.5,h:0.4, fill:{ color:DARK } });
  s.addText("TARGET:  PASI-75 by Week 16   |   PASI-90 by Month 6   |   Sustained PASI-90 for long-term maintenance",{
    x:0.4,y:5.0,w:9.1,h:0.4, fontSize:10,bold:true,color:WHITE,align:"center",valign:"middle"
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 16 – COUNSELLING PART 1
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PATIENT COUNSELLING","Part 1 – Disease Education & Medication");
  footer(s,16,"Patient Counselling – Part 1");

  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.95, fill:{ color:LIGHT }, line:{ color:MID,width:1.5 } });
  s.addShape(prs.ShapeType.rect,{ x:0.25,y:1.18,w:9.5,h:0.36, fill:{ color:MID } });
  s.addText("DISEASE EDUCATION",{ x:0.4,y:1.18,w:9.1,h:0.36, fontSize:SMALL,bold:true,color:WHITE,charSpacing:2,valign:"middle",margin:0 });
  ["Psoriasis is a long-term autoimmune skin disease — it is NOT contagious.",
   "Treatment controls symptoms and prevents flare-ups; it does not permanently cure the disease."
  ].forEach((e,i)=>{
    s.addText("•  "+e,{ x:0.4,y:1.58+i*0.3,w:9.1,h:0.28, fontSize:SMALL+0.5,color:TEXT_M });
  });

  [
    { name:"Cyclosporine",           shade:DARK, points:["Take regularly as prescribed","Avoid grapefruit juice (↑ drug levels)","Report reduced urine output or swelling","Monitor blood pressure at home regularly"] },
    { name:"Secukinumab (Biologic)", shade:MID,  points:["Store injection in refrigerator (2–8°C)","Rotate injection site each time","Report fever, cough, or signs of infection","Do not miss doses — follow schedule strictly"] },
  ].forEach((m,i)=>{
    const x=0.25+i*4.9;
    s.addShape(prs.ShapeType.rect,{ x,y:2.28,w:4.65,h:2.85, fill:{ color:LIGHT }, line:{ color:m.shade,width:1.5 } });
    s.addShape(prs.ShapeType.rect,{ x,y:2.28,w:4.65,h:0.42, fill:{ color:m.shade } });
    s.addText(m.name,{ x:x+0.12,y:2.28,w:4.4,h:0.42, fontSize:11,bold:true,color:WHITE,valign:"middle",margin:0 });
    m.points.forEach((p,pi)=>{
      s.addText("→  "+p,{ x:x+0.15,y:2.74+pi*0.56,w:4.35,h:0.52, fontSize:SMALL+0.5,color:TEXT_M,valign:"middle" });
    });
  });
}

// ═══════════════════════════════════════════════════════════════════
// SLIDE 17 – COUNSELLING PART 2 + THANK YOU
// ═══════════════════════════════════════════════════════════════════
{
  const s = prs.addSlide(); bgLight(s);
  titleBar(s,"PATIENT COUNSELLING","Part 2 – Topical Steroids & Lifestyle");
  footer(s,17,"Patient Counselling – Part 2");

  card(s,0.25,1.18,4.65,2.0,"TOPICAL STEROIDS",DARK);
  ["Apply only a thin layer to affected areas","Do not use longer than prescribed",
   "Wash hands after applying medication","Do not apply to face unless specifically directed"
  ].forEach((p,i)=>{
    s.addText("→  "+p,{ x:0.4,y:1.62+i*0.37,w:4.4,h:0.34, fontSize:SMALL+0.5,color:TEXT_M });
  });

  card(s,0.25,3.32,4.65,1.82,"LIFESTYLE COUNSELLING",MID);
  ["Use moisturizers daily to keep skin hydrated","Avoid scratching the lesions",
   "Manage stress through relaxation and adequate sleep","Stop smoking and limit alcohol intake"
  ].forEach((p,i)=>{
    s.addText("✓  "+p,{ x:0.4,y:3.78+i*0.34,w:4.4,h:0.31, fontSize:SMALL+0.5,color:TEXT_M });
  });

  // Thank you panel – deep indigo
  s.addShape(prs.ShapeType.rect,{ x:5.1,y:1.18,w:4.65,h:3.96, fill:{ color:DARK }, line:{ color:MID,width:2 } });
  s.addShape(prs.ShapeType.ellipse,{ x:5.5,y:0.9,w:3.2,h:3.2, fill:{ color:MID, transparency:88 } });
  s.addText("Thank You",{ x:5.2,y:1.55,w:4.4,h:0.9, fontSize:34,bold:true,color:WHITE,align:"center" });
  s.addShape(prs.ShapeType.line,{ x:5.65,y:2.52,w:3.4,h:0, line:{ color:MID,width:2 } });
  s.addText("Questions & Discussion",{ x:5.2,y:2.6,w:4.4,h:0.42, fontSize:14,color:LIGHT,align:"center",italic:true });

  s.addShape(prs.ShapeType.rect,{ x:5.28,y:3.15,w:4.3,h:1.6, fill:{ color:"0D1454" }, line:{ color:MID,width:1 } });
  s.addText("CASE SUMMARY",{ x:5.4,y:3.2,w:4.0,h:0.28, fontSize:SMALL,bold:true,color:LIGHT,charSpacing:3,align:"center" });
  s.addText("50M  ·  Severe Plaque Psoriasis\n27-yr refractory disease\nRec: Secukinumab + Cyclosporine bridge\n+ Topicals + Cetirizine + Emollients",{
    x:5.4,y:3.52,w:4.0,h:1.16, fontSize:SMALL+0.5,color:WHITE,align:"center"
  });
}

// ─── WRITE ────────────────────────────────────────────────────────
prs.writeFile({ fileName:"/home/daytona/workspace/plaque-psoriasis-ppt/Plaque_Psoriasis_Blue_Indigo.pptx" })
  .then(()=>console.log("SUCCESS"))
  .catch(e=>{ console.error("ERROR:",e); process.exit(1); });

Running Command

cd /home/daytona/workspace/plaque-psoriasis-ppt && node build_blue.js 2>&1

Running Command

ls -lh /home/daytona/workspace/plaque-psoriasis-ppt/Plaque_Psoriasis_Blue_Indigo.pptx

Your Blue / Indigo monochromatic presentation is ready:

Plaque Psoriasis Blue Indigo

Presentation · PPTX

Three shades used — exclusively Blue / Indigo:

Shade	Hex	Role
Deep Indigo `■`	`#1A237E`	Header bars, primary card headers, odd DTP cards, dark accents
Mid Blue `■`	`#3F51B5`	Sub-bands, even cards, divider strips, location chips
Pale Lavender-Blue `■`	`#E8EAF6`	Slide card fills, alternating table rows, footer strips

All 17 slides included with the same structure as before — headline at 28 pt bold, sub-headline at 24 pt italic, white light background with blue-indigo elements throughout. No other colours used.

This is a shared conversation. Sign in to Orris to start your own chat.